interCLICK, Inc. Common Stock PLACEMENT AGENT AGREEMENT
4,025,000
Common
Stock
December
15, 2009
RBC
CAPITAL MARKETS CORPORATION
XXXXXXXX
CURHAN FORD & CO.
c/o RBC
Capital Markets Corporation
Three
World Financial Center, 000 Xxxxx Xxxxxx
Xxx Xxxx,
Xxx Xxxx 00000
Ladies
and Gentlemen:
1. Introduction. interCLICK,
Inc., a Delaware
corporation (the “Company”), and the
stockholders of the Company named on Schedule C hereto
(the “Selling
Shareholders”) confirm their respective agreements (i) for the Company to
issue and sell to the investors, pursuant to the terms and conditions of this
Placement Agent Agreement (this “Agreement”) and the
Subscription Agreements in the form of Exhibit A attached hereto
(the “Subscription
Agreements”) entered into with the investors identified therein (each a
“Investor” and,
collectively, the “Investors”), up to an
aggregate of 2,875,000 shares of common stock, $0.001 par value per share (the
“Common Stock”) of the
Company (the “Company
Stock”), and (ii) for the Selling Shareholders, severally and not
jointly, to sell to the Investors pursuant to the terms and conditions of this
Agreement and the Subscription Agreements entered into with the Investors up to
an aggregate of 1,150,000 shares of Common Stock (the “Selling Shareholder Stock”,
and together with the Company Stock, the “Stock”). The number
of shares of Selling Shareholder Stock to be sold by each Selling Shareholder is
set forth opposite such Selling Shareholder’s name on Schedule C
hereto. The Company and the Selling Shareholders hereby confirm
that RBC Capital Markets Corporation (“RBCCM”) and Xxxxxxxx Curhan
Ford & Co. (“MCFC”,
and together with RBCCM, the “Placement Agents”) acted as
Placement Agents in accordance with the terms and conditions
hereof. RBCCM is acting as the representative of the Placement Agents
and in such capacity is hereinafter referred to as the “Representative.”
2. Agreement to Act as Placement
Agents; Placement of Securities. On
the basis of the representations, warranties and agreements of the Company and
the Selling Shareholders herein contained, and subject to all the terms and
conditions of this Agreement:
2.1 The
Company and the Selling Shareholders have authorized and hereby acknowledge that
the Placement Agents have acted as its exclusive agents to solicit offers for
the purchase of all or part of the Stock from the Company and the Selling
Shareholders in connection with the proposed offering of the Stock (the “Offering”). Until
the Closing Date (as defined in Section 4 hereof),
the Company and the Selling Shareholders shall not, without the prior written
consent of the Representative, solicit or accept offers to purchase Stock
otherwise than through the Placement Agents.
2.2 The
Company and the Selling Shareholders hereby acknowledge that the Placement
Agents, as agents of the Company and the Selling Shareholders, used their
commercially reasonable efforts to solicit offers to purchase the Stock from the
Company and the Selling Shareholders on the terms and subject to the conditions
set forth in the Prospectus (as defined below). The Placement Agents shall use
their commercially reasonable efforts to assist the Company in obtaining
performance by each Investor whose offer to purchase Stock was solicited by the
Placement Agents and accepted by the Company and the Selling Shareholders, but
the Placement Agents shall not, except as otherwise provided in this Agreement,
be obligated to disclose the identity of any potential Investor or have any
liability to the Company or any Selling Shareholder in the event any such
purchase is not consummated for any reason. Under no circumstances will the
Placement Agents be obligated to underwrite or purchase any Stock for their own
account and, in soliciting purchases of Stock, the Placement Agents acted solely
as the Company’s and the Selling Shareholders’ agents and not as
principals. Notwithstanding the foregoing and except as otherwise
provided in Section
2.3, it is understood and agreed that the Placement Agents (or their
respective affiliates) may, solely at its discretion and without any obligation
to do so, purchase Stock as principals, on the same terms, and subject to the
same conditions, as set forth in the Prospectus.
2.3 Subject
to the provisions of this Section 2, offers for
the purchase of Stock were solicited by the Placement Agents as agents for the
Company and the Selling Shareholders’ at such times and in such amounts as the
Placement Agents deemed advisable. The Representative communicated to
the Company and the Selling Shareholders’, orally or in writing, each reasonable
offer to purchase Stock received by the Placement Agents as agents of the
Company and the Selling Shareholders. Each of the Company and the Selling
Shareholders, individually, shall have the sole right to accept offers to
purchase the Stock and may reject any such offer, in whole or in part. The
Representative has the right, in its discretion reasonably exercised, without
notice to the Company or to the Selling Shareholders, to reject any offer to
purchase Stock received by the Placement Agents, in whole or in part, and any
such rejection shall not be deemed a breach of this Agreement; the determination
and the identity of the offeree has been disclosed to the Company and the
Selling Shareholders.
2.4 The
Stock is being sold to the Investors at a price of $4.50 per
share. The purchases of the Stock by the Investors shall be evidenced
by the execution of Subscription Agreements by each of the Investors and the
Company and the Selling Shareholders.
2.5 As
compensation for services rendered to the Company, on the Closing Date (as
defined in Section
4 hereof), the Company shall pay to the Representative by wire transfer
of immediately available funds to an account or accounts designated by the
Representative, an amount (the “Placement Fee”) equal to seven
(7.0%) percent of the gross proceeds received by the Company from the sale of
the Stock on such Closing Date. The Placement Fee shall also be paid
for services rendered to the Selling Shareholders, for sales of the Stock to be
sold by each such Selling Shareholder hereunder, which shall be deducted from
the Selling Shareholders’ proceeds from the sale of such Stock and wired by the
purchasers of such stock to an account or accounts designated by the
Representative in immediately available funds.
2
2.6 No
Stock which the Company and the Selling Shareholders have agreed to sell
pursuant to this Agreement and the Subscription Agreements shall be deemed to
have been purchased and paid for, or sold by the Company and the Selling
Shareholders, until such Stock shall have been delivered to the Investor thereof
against payment by such Investor. If the Company or the Selling Shareholders
shall default in its obligations to deliver Stock to a Investor whose offer it
has accepted, the Company or the Selling Shareholders, as applicable, in each
case severally, and not jointly, shall indemnify and hold the Placement Agents
harmless against any loss, claim, obligation, contingency, damage, cost,
liability or expense (including reasonable attorney’s fees and expenses),
including all judgments, amounts paid in settlements, court costs and costs of
preparation and investigation (“Losses”) arising from or as a
result of such default by the Company or such Selling Shareholder in accordance
with the procedures set forth in Section 8(c)
herein.
3. Representations and Warranties of
the Company. The
Company represents and warrants to, and agrees with, the Placement Agents and
the Investors that:
(a) The
Company has filed in conformity with the requirements of the Securities Act of
1933, as amended (the “Securities Act”), and
published rules and regulations thereunder (the “Rules and Regulations”)
adopted by the Securities and Exchange Commission (the “Commission”) a “shelf”
Registration Statement (as hereinafter defined) on Form S-3 (File No.
333-163159), which became effective as of 9:30 a.m. Eastern Time on November 30,
2009 (the “Effective
Date”), including a base prospectus relating to the Shares (the “Base Prospectus”), and such
amendments and supplements thereto as may have been required to the date of this
Agreement. The term “Registration Statement” as
used in this Agreement means the registration statement on Form S-3 (including
all exhibits thereto deemed to be a part of the Registration Statement pursuant
to the Rules and Regulations), as amended and/or supplemented to the date of
this Agreement, including the Base Prospectus. The Registration
Statement is effective under the Securities Act and no stop order preventing or
suspending the effectiveness of the Registration Statement or suspending or
preventing the use of the Prospectus has been issued by the Commission and no
proceedings for that purpose have been instituted or, to the knowledge of the
Company, are threatened by the Commission. The Company, if required
by the Rules and Regulations of the Commission, will file the Prospectus (as
defined below), with the Commission pursuant to Rule 424(b) of the Rules and
Regulations. The term “Prospectus” as used in this
Agreement means the prospectus, in the form in which it is to be filed with the
Commission pursuant to Rule 424(b) of the Rules and Regulations, or, if the
prospectus is not to be filed with the Commission pursuant to Rule 424(b), the
prospectus in the form included as part of the Registration Statement as of the
Effective Date, except that if any revised prospectus or prospectus supplement
shall be provided to the Placement Agents by the Company for use in connection
with the offering and sale of the Stock which differs from the Prospectus
(whether or not such revised prospectus or prospectus supplement is required to
be filed by the Company pursuant to Rule 424(b) of the Rules and Regulations),
the term “Prospectus”
shall refer to such revised prospectus or prospectus supplement, as the case may
be, from and after the time it is first provided to the Placement Agents for
such use. Any preliminary prospectus or prospectus subject to completion
included in the Registration Statement or filed with the Commission pursuant to
Rule 424 of the Rules and Regulations is hereafter called a “Preliminary
Prospectus.” Any reference herein to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer
to and include the documents incorporated by reference therein pursuant to Item
12 of Form S-3 which were filed under the Securities Exchange Act of 1934, as
amended (the “Exchange
Act”), on or before the last to occur of the Effective Date, the date of
the Preliminary Prospectus, or the date of the Prospectus, and any reference
herein to the terms “amend,” “amendment,” or “supplement” with respect to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include (i) the filing of any document under the Exchange
Act after the Effective Date, the date of such Preliminary Prospectus or the
date of the Prospectus, as the case may be, which is incorporated by reference
and (ii) any such document so filed. If the Company has filed an abbreviated
registration statement to register additional securities pursuant to Rule 462(b)
under the Rules (the “462(b)
Registration Statement”), then any reference herein to the Registration
Statement shall also be deemed to include such 462(b) Registration
Statement.
3
(b) As
of the Applicable Time (as defined below) and as of the Closing Date, neither
(i) any General Use Free Writing Prospectus (as defined below) issued at or
prior to the Applicable Time and the Pricing Prospectus (as defined below) and
the information included on Schedule A hereto, all
considered together (collectively, the “General Disclosure Package”),
(ii) any individual Limited Use Free Writing Prospectus (as defined below) nor
(iii) the bona fide electronic road show (as defined in Rule 433(h)(5) of the
Rules and Regulations), if any, that has been made available without restriction
to any person, when considered together with the General Disclosure Package,
included or will include, any untrue statement of a material fact or omitted or
as of the Closing Date will omit, to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they
were made, not misleading; provided, however, that the
Company makes no representations or warranties as to information contained in or
omitted from the General Disclosure Package, in reliance upon, and in conformity
with, written information furnished to the Company by the Placement Agent
specifically for inclusion therein, which information the parties hereto agree
is limited to the Placement Agents’ Information (as defined in Section
18). As used in this paragraph (b) and
elsewhere in this Agreement:
“Applicable
Time” means 5:25 P.M., New York time, on the date of this
Agreement.
“General Use Free
Writing Prospectus” means any Issuer Free Writing Prospectus that is
identified on Schedule
A to
this Agreement.
“Issuer Free
Writing Prospectus” means any “issuer free writing
prospectus,” as defined in Rule 433 of the Rules and Regulations relating
to the Stock in the form filed or required to be filed with the Commission or,
if not required to be filed, in the form retained in the Company’s records
pursuant to Rule 433(g) of the Rules and Regulations.
4
“Limited Use Free
Writing Prospectuses” means any Issuer Free Writing Prospectus that is
not a General Use Free Writing Prospectus.
“Pricing
Prospectus” means the Preliminary Prospectus, if any, and the Base
Prospectus, each as amended and supplemented immediately prior to the Applicable
Time, including any document incorporated by reference therein and any
prospectus supplement deemed to be a part thereof.
(c) No
order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus relating to the Offering has been
issued by the Commission, and no proceeding for that purpose or pursuant to
Section 8A of the Securities Act has been instituted or, to the Company’s
knowledge, is threatened, by the Commission, and each Preliminary Prospectus (if
any), at the time of filing thereof, conformed in all material respects to the
requirements of the Securities Act and the Rules and Regulations, and did not
contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided, however, that the
Company makes no representations or warranties as to information contained in or
omitted from any Preliminary Prospectus, any Issuer Free Writing Prospectus or
the Prospectus relating to the Offering in reliance upon, and in conformity
with, written information furnished to the Company by the Placement Agent
specifically for inclusion therein, which information the parties hereto agree
is limited to the Placement Agents’ Information.
(d) At
the time the Registration Statement became effective, at the date of this
Agreement and at the Closing Date, the Registration Statement conformed and will
conform in all material respects to the requirements of the Securities Act and
the Rules and Regulations and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading; the
Prospectus, at the time the Prospectus was issued and at the Closing Date,
conformed and will conform in all material respects to the requirements of the
Securities Act and the Rules and Regulations and did not and will not contain an
untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading; provided, however, that the
foregoing representations and warranties in this paragraph (d) shall
not apply to information contained in or omitted from the Registration Statement
or the Prospectus in reliance upon, and in conformity with, written information
furnished to the Company by the Placement Agents specifically for inclusion
therein, which information the parties hereto agree is limited to the Placement
Agents’ Information. At the time the Registration Statement was filed
with and declared effective by the Commission, the Company was eligible to
register the Stock issued in connection with the Offering contemplated by this
Agreement on Form S-3 promulgated under the Securities Act, and as of the date
hereof, remains eligible to use the Form S-3 Registration
Statement.
5
(e) Each
Issuer Free Writing Prospectus, if any, as of its issue date and at all
subsequent times through the completion of the public offer and sale of the
Stock or until any earlier date that the Company notified or notifies the
Representative as described in Section 5(e), did
not, does not and will not include any information that conflicted, conflicts or
will conflict with the information contained in the Registration Statement,
Pricing Prospectus, if any, or the Prospectus, including any document
incorporated by reference therein and any prospectus supplement deemed to be a
part thereof that has not been superseded or modified, or includes an untrue
statement of a material fact or omitted or would omit to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading. The foregoing sentence does not apply to statements in or
omissions from any Issuer Free Writing Prospectus in reliance upon, and in
conformity with, written information furnished to the Company by the Placement
Agents specifically for inclusion therein, which information the parties hereto
agree is limited to the Placement Agents’ Information.
(f) The
documents incorporated by reference in the Prospectus, when they became
effective or were filed with the Commission, as the case may be, conformed in
all material respects to the requirements of the Securities Act or the Exchange
Act, as applicable, and the rules and regulations of the Commission thereunder
and none of such documents contained any untrue statement of a material fact or
omitted to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading; and any further documents so filed and incorporated by
reference in the Prospectus, when such documents become effective or are filed
with the Commission, as the case may be, will conform in all material respects
to the requirements of the Securities Act or the Exchange Act, as applicable,
and the rules and regulations of the Commission thereunder and will not contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not
misleading.
(g) The
Company has not, directly or indirectly, distributed and will not distribute any
offering material in connection with the Offering other than any Preliminary
Prospectus, if any, the Prospectus and other materials, if any, permitted under
the Securities Act and consistent with Section 5(b)
below.
(h) The
Company and each of its Subsidiaries (as defined in Section 16) have been
duly organized and are validly existing as corporations in good standing (or the
foreign equivalent thereof) under the laws of their respective jurisdictions of
organization. The Company and each of its Subsidiaries are duly
qualified to do business and are in good standing as foreign corporations in
each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification and have
all power and authority (corporate or other) necessary to own or hold their
respective properties and to conduct the businesses in which they are engaged,
except where the failure to so qualify or have such power or authority (i) would
not have, singularly or in the aggregate, a material adverse effect on the
condition (financial or otherwise), results of operations, assets, business or
prospects of the Company and its Subsidiaries taken as a whole, or (ii) impair
in any material respect the ability of the Company to perform its obligations
under this Agreement or to consummate any transactions contemplated by the
Agreement, the General Disclosure Package or the Prospectus (any such effect as
described in clauses (i) or (ii), a “Material Adverse
Effect”).
6
(i) The
Company has the full right, power and authority to enter into this Agreement,
each of the Subscription Agreements dated as of the date hereof by and among the
Company and the Placement Agents and that certain Escrow Agreement (the “Escrow Agreement”) among the
Company, the Selling Shareholders and the escrow agent named therein and to
perform and to discharge its obligations hereunder and thereunder; and each of
this Agreement, each of the Subscription Agreements and the Escrow Agreement has
been duly authorized, executed and delivered by the Company, and constitutes a
valid and binding obligation of the Company enforceable in accordance with its
terms.
(j) The
Stock to be issued and sold by the Company to the Investors hereunder and under
the Subscription Agreements has been duly and validly authorized and, when
issued and delivered against payment therefor as provided herein and the
Subscription Agreements, will be duly and validly issued, fully paid and
nonassessable free and clear of all lien, charge, claim, encumbrance, security
interest, right of first refusal, preemptive right or other restrictions of any
kind, other than restrictions on transfer of securities arising under federal or
state securities laws and regulations (collectively, “Liens”) and free of any
preemptive or similar rights and will conform to the description thereof
contained in the General Disclosure Package and the Prospectus.
(k) The
Company has an authorized capitalization as set forth in the Company’s Quarterly
Report on Form 10-Q for the quarterly period ended September 30, 2009, and all
of the issued shares of capital stock of the Company have been duly and validly
authorized and issued, are fully paid and non-assessable, have been issued in
compliance with federal and state securities laws, and conform to the
description thereof contained in the General Disclosure Package and the
Prospectus. As of December 15, 2009, there were 20,720,207 shares of
Common Stock issued and outstanding and zero shares of Preferred Stock, par
value $0.001 of the Company issued and outstanding and 6,453,476 shares of
Common Stock were issuable upon the exercise of all options, warrants and
convertible securities outstanding as of such date. Since such date, the Company
has not issued any securities, other than Common Stock of the Company issued
pursuant to the exercise of stock options previously outstanding under the
Company’s stock option plans or the issuance of restricted Common Stock pursuant
to employee stock purchase plans. All of the Company’s options,
warrants and other rights to purchase or exchange any securities for shares of
the Company’s capital stock have been duly authorized and validly issued and
were issued in compliance with U.S. federal and state securities
laws. None of the outstanding shares of Common Stock was issued in
violation of any preemptive rights, rights of first refusal or other similar
rights to subscribe for or purchase securities of the Company. There
are no authorized or outstanding shares of capital stock, options, warrants,
preemptive rights, rights of first refusal or other rights to purchase, or
equity or debt securities convertible into or exchangeable or exercisable for,
any capital stock of the Company or any of its subsidiaries other than those
described above or accurately described in the General Disclosure
Package. The description of the Company’s stock option, stock bonus
and other stock plans or arrangements, and the options or other rights granted
thereunder, as described in the General Disclosure Package and the Prospectus,
accurately and fairly present the information required to be shown with respect
to such plans, arrangements, options and rights. The issue and sale
of the Stock will not, immediately or with the passage of time, obligate the
Company to issue shares of Common Stock or other securities to any person (other
than the Investors) and will not result in a right of any holder of Company
securities to adjust the exercise, conversion, exchange or reset price under
such securities.
7
(l) All
the outstanding shares of capital stock of each Subsidiary of the Company have
been duly authorized and validly issued, are fully paid and nonassessable and,
except to the extent set forth in the General Disclosure Package or the
Prospectus, are owned by the Company directly or indirectly through one or more
wholly-owned subsidiaries, free and clear of any Lien.
(m) The
execution, delivery and performance of this Agreement, the Subscription
Agreements and the Escrow Agreement by the Company, the issue and sale of the
Stock by the Company and the consummation of the transactions contemplated
hereby and thereby will not (with or without notice or lapse of time or both)
conflict with or result in a breach or violation of any of the terms or
provisions of, constitute a default or Debt Repayment Triggering Event (as
defined below) under, give rise to any right of termination or other right or
the cancellation or acceleration of any right or obligation or loss of a benefit
under, or give rise to the creation or imposition of any Lien upon any property
or assets of the Company or any Subsidiary pursuant to, any indenture, mortgage,
deed of trust, loan agreement or other agreement or instrument to which the
Company or any of its Subsidiaries is a party or by which the Company or any of
its Subsidiaries is bound or to which any of the property or assets of the
Company or any of its Subsidiaries is subject, nor will such actions result in
any violation of the provisions of the charter or by-laws (or analogous
governing instruments, as applicable) of the Company or any of its Subsidiaries
or any law, statute, rule, regulation, judgment, order or decree of any court or
governmental agency or body, domestic or foreign, having jurisdiction over the
Company or any of its Subsidiaries or any of their properties or
assets. A “Debt
Repayment Triggering Event” means any event or condition that gives, or
with the giving of notice or lapse of time, would give the holder of any note,
debenture or other evidence of indebtedness (or any person acting on such
holder’s behalf) the right to require the repurchase, redemption or repayment of
all or a portion of such indebtedness by the Company or any of its
subsidiaries.
(n) Except
for the registration of the Stock under the Securities Act and such consents,
approvals, authorizations, registrations or qualifications as may be required
under the Exchange Act and applicable state or foreign securities laws, the
Financial Industry Regulatory Authority (“FINRA”) and The Nasdaq Capital
Market (“NCM”) in
connection with the offering and sale of the Stock by the Company, no consent,
approval, authorization or order of, or filing, qualification or registration
with, any court or governmental agency or body, foreign or domestic, which has
not been made, obtained or taken and is not in full force and effect, is
required for the execution, delivery and performance of this Agreement, the
Subscription Agreements and the Escrow Agreement by the Company, the offer or
sale of the Stock or the consummation of the transactions contemplated hereby or
thereby.
8
(o) Xxxxxxx
& Company, P.A., who have certified certain consolidated financial
statements included or incorporated by reference in the Registration Statement,
the General Disclosure Package and the Prospectus, is an independent registered
public accounting firm as required by the Securities Act and the Rules and
Regulations and the Public Company Accounting Oversight Board (United States)
(the “PCAOB”). Xxxxxxx
& Company, P.A. has not been engaged by
the Company to perform any “prohibited activities” (as defined in Section 10A of
the Exchange Act). Effective October 5, 2009, the Company changed
auditors from Xxxxxxx & Company, P.A. to X.X. Xxxx LLP. During
the period from the date of original engagement by the Company through the date
of their dismissal, the Company had no disagreements with Xxxxxxx & Company,
P.A. on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedures, which disagreements, if not
resolved to the former auditors’ satisfaction, would have caused them to make
reference to the subject matter of the disagreement in connection with their
report on the Company’s consolidated financial statements.
(p) The
Company has filed all SEC Reports (as defined below) on a timely basis or has
timely filed a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the
requirements of Securities Act and the rules and regulations of the Commission
promulgated thereunder and the Exchange Act and the rules and regulations of the
Commission promulgated thereunder, and none of the SEC Reports, when filed,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading. The financial statements, together with the related notes
and schedules, included or incorporated by reference in the General Disclosure
Package, the Prospectus and in the Registration Statement fairly present the
financial position and the results of operations and changes in financial
position of the Company and its consolidated Subsidiaries at the respective
dates or for the respective periods therein specified. Such
statements and related notes and schedules have been prepared in accordance with
the generally accepted accounting principles in the United States (“GAAP”) applied on a consistent
basis throughout the periods involved except as may be set forth in the related
notes included or incorporated by reference in the General Disclosure
Package. The financial statements, together with the related notes
and schedules, included or incorporated by reference in the General Disclosure
Package and the Prospectus comply in all material respects with the Securities
Act, the Exchange Act, and the Rules and Regulations and the rules and
regulations under the Exchange Act. No other financial statements or
supporting schedules or exhibits are required by the Securities Act or the Rules
and Regulations to be described, or included or incorporated by reference in the
Registration Statement, the General Disclosure Package or the
Prospectus. There is no pro forma or as adjusted financial
information which is required to be included in the Registration Statement, the
General Disclosure Package, or and the Prospectus or a document incorporated by
reference therein in accordance with the Securities Act and the Rules and
Regulations which has not been included or incorporated as so
required. The pro forma and pro forma as adjusted financial
information and the related notes included or incorporated by reference in the
Registration Statement, the General Disclosure Package and the Prospectus have
been properly compiled and prepared in accordance with the applicable
requirements of the Securities Act and the Rules and Regulations and present
fairly the information shown therein, and the assumptions used in the
preparation thereof are reasonable and the adjustments used therein are
appropriate to give effect to the transactions and circumstances referred to
therein.
9
(q) Neither
the Company nor any of its subsidiaries has sustained, since the date of the
latest audited financial statements included or incorporated by reference in the
General Disclosure Package, any material loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor dispute or court or governmental action, order or
decree, otherwise than as set forth or contemplated in the General Disclosure
Package; and, since such date, (i) neither the Company nor any of its
Subsidiaries has incurred any material liabilities or obligations, direct or
contingent, or entered into any material transactions other than in the ordinary
course of business and required to be reflected in the Company’s consolidated
financial statements pursuant to GAAP or required to be disclosed in filings
made by the Company with the Commission, (ii) other than a reverse stock split
in which each two shares of capital stock issued and outstanding prior to
effectiveness of such split was reduced to one share of capital stock, effective
October 27, 2009, the Company has not declared or paid any dividends or made any
distribution of any kind with respect to its capital stock; (iii) there has not
been any change in the capital stock of the Company or any of its Subsidiaries
(other than a change in the number of outstanding shares of Common Stock due to
the issuance of shares upon the exercise of outstanding options or warrants or
the issuance of restricted stock awards or restricted stock units under the
Company’s existing stock awards plan, or any new grants thereof in the ordinary
course of business, and issuances in exchange for extensions of indebtedness and
interest thereon and waivers thereto and which have been publicly disclosed in
the Company’s SEC Reports), (iv) there has not been any material change in the
Company’s long-term or short-term debt required to be reflected in the Company’s
consolidated financial statements pursuant to GAAP or required to be disclosed
in filings made by the Company with the Commission, and (v) there has not been
an occurrence that has had or could, individually or in the aggregate, have a
Material Adverse Effect.
(r) Except
as set forth in the General Disclosure Package, there is no Action (as defined
below) pending to which the Company or any of its Subsidiaries is a party or of
which any property or assets of the Company or any of its Subsidiaries is the
subject which is required to be described in the Registration Statement, the
General Disclosure Package or the Prospectus or a document incorporated by
reference therein and is not described therein, or which, singularly or in the
aggregate, if determined adversely to the Company or any of its subsidiaries,
could have a Material Adverse Effect or prevent the consummation of the
transactions contemplated hereby; and to the best of the Company’s knowledge, no
such Action is threatened or contemplated by governmental authorities or
threatened by others. “Action” means any action,
claim, suit, inquiry, notice of violation, proceeding (including any partial
proceeding such as a deposition) or investigation pending or, to the knowledge
of the Company, threatened against or affecting the Company or any Subsidiary or
any of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign).
10
(s) Neither
the Company nor any of its Subsidiaries is in (i) violation of its charter or
by-laws (or analogous governing instrument, as applicable), (ii) default in any
respect, and no event has occurred which, with notice or lapse of time or both,
would constitute such a default, in the due performance or observance of any
term, covenant or condition contained in any indenture, mortgage, deed of trust,
loan agreement, lease or other agreement or instrument to which it is a party or
by which it is bound or to which any of its property or assets is subject or
(iii) violation in any respect of any law, ordinance, governmental rule,
regulation or court order, decree or judgment to which it or its property or
assets may be subject except, in the case of clauses (ii) and (iii) of this
paragraph (s), for any violations or defaults which, singularly or in the
aggregate, would not have a Material Adverse Effect.
(t) The
Company and each of its Subsidiaries possess all licenses, certificates,
authorizations and permits issued by, and have made all declarations and filings
with, the appropriate local, state, federal or foreign regulatory agencies or
bodies which are necessary or desirable for the ownership of their respective
properties or the conduct of their respective businesses as described in the
General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except
where any failures to possess or make the same, singularly or in the aggregate,
would not have a Material Adverse Effect. The Company and its
Subsidiaries are in compliance with all such Governmental Permits; all such
Governmental Permits are valid and in full force and effect, except where the
validity or failure to be in full force and effect would not, singularly or in
the aggregate, have a Material Adverse Effect. All such Governmental
Permits are free and clear of any restriction or condition that are in addition
to, or materially different from those normally applicable to similar licenses,
certificates, authorizations and permits. Neither the Company nor any of its
Subsidiaries has received notification of any revocation or modification (or
proceedings related thereto) of any such Governmental Permit and the Company has
no reason to believe that any such Governmental Permit will not be
renewed.
(u) Neither
the Company nor any of its subsidiaries is or, after giving effect to the
offering of the Stock and the application of the proceeds thereof as described
in the General Disclosure Package and the Prospectus, will become an “investment
company” within the meaning of the Investment Company Act of 1940, as amended,
and the rules and regulations of the Commission thereunder.
11
(v) Neither
the Company, its Subsidiaries nor, to the Company’s knowledge, any of the
Company’s or its subsidiaries’ officers, directors or affiliates has taken or
will take, directly or indirectly, any action designed or intended to stabilize
or manipulate the price of any security of the Company, or which caused or
resulted in, or which might in the future reasonably be expected to cause or
result in, stabilization or manipulation of the price of any security of the
Company.
(w) The
Company and its Subsidiaries own or possess the right to use all patents,
trademarks, trademark registrations, service marks, service xxxx registrations,
trade names, copyrights, licenses, inventions, software, databases, know-how,
Internet domain names, trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems or procedures, and other
intellectual property (collectively, “Intellectual Property”)
necessary to carry on their respective businesses as currently conducted, and as
proposed to be conducted and described in the General Disclosure Package and
the Prospectus, and the Company is not aware of any claim to the
contrary or any challenge by any other person to the rights of the Company and
its Subsidiaries with respect to the foregoing except for those that could not
have a Material Adverse Effect. The Intellectual Property licenses
described in the General Disclosure Package and the Prospectus are valid,
binding upon, and enforceable by or against the parties thereto in accordance to
its terms. The Company and each of its Subsidiaries has complied in
all material respects with, and is not in breach nor has received any asserted
or threatened claim of breach of, any Intellectual Property license, and the
Company has no knowledge of any breach or anticipated breach by any other person
to any Intellectual Property license. The Company’s and each of its
Subsidiaries’ businesses as now conducted and as proposed to be conducted do not
and will not infringe or conflict with any patents, trademarks, service marks,
trade names, copyrights, trade secrets, licenses or other Intellectual Property
or franchise right of any person. No claim has been made against the
Company or any of its Subsidiaries alleging the infringement by the Company or
any of its Subsidiaries of any patent, trademark, service xxxx, trade name,
copyright, trade secret, license in or other intellectual property right or
franchise right of any person. The Company and each of its
Subsidiaries has taken all reasonable steps to protect, maintain and safeguard
its rights in all Intellectual Property, including the execution of appropriate
nondisclosure and confidentiality agreements. The consummation of the
transactions contemplated by this Agreement will not result in the loss or
impairment of or payment of any additional amounts with respect to, nor require
the consent of any other person in respect of, the Company’s or any of its
Subsidiaries’ right to own, use, or hold for use any of the Intellectual
Property as owned, used or held for use in the conduct of the businesses as
currently conducted. With respect to the use of the software in the
Company’s or any of its Subsidiaries’ businesses as they are currently
conducted, the Company nor any of its Subsidiaries has experienced any material
defects in such software including any material error or omission in the
processing of any transactions other than defects which have been corrected, and
to the knowledge of the Company, no such software contains any device or feature
designed to disrupt, disable, or otherwise impair the functioning of any
software or is subject to the terms of any “open source” or other similar
license that provides for the source code of the software to be publicly
distributed or dedicated to the public. The Company and each of its
Subsidiaries has at all times complied with all applicable laws relating to
privacy, data protection, and the collection and use of personal information
collected, used, or held for use by the Company and any of its Subsidiaries in
the conduct of the Company’s and its Subsidiaries businesses. No
claims have been asserted or threatened against the Company or any of its
Subsidiaries alleging a violation of any person’s privacy or personal
information or data rights and the consummation of the transactions contemplated
hereby will not breach or otherwise cause any violation of any law related to
privacy, data protection, or the collection and use of personal information
collected, used, or held for use by the Company or any of its Subsidiaries in
the conduct of the Company’s or any of its Subsidiaries’
businesses. The Company and each of its Subsidiaries takes reasonable
measures to ensure that such information is protected against unauthorized
access, use, modification, or other misuse.
12
(x) The
Company and each of its Subsidiaries have good and marketable title in fee
simple to, or have valid rights to lease or otherwise use, all items of real or
personal property which are material to the business of the Company and its
Subsidiaries taken as a whole, in each case free and clear of all Liens that do
not, singularly or in the aggregate, materially affect the value of such
property and do not interfere with the use made and proposed to be made of such
property by the Company or any of its Subsidiaries; and all of the leases and
subleases material to the business of The Company and its Subsidiaries,
considered as one enterprise, and under which the Company or any of its
Subsidiaries holds properties described in the General Disclosure Package and
the Prospectus, are in full force and effect, and neither the Company nor any
Subsidiary has received any notice of any material claim of any sort that has
been asserted by anyone adverse to the rights of the Company or any Subsidiary
under any of the leases or subleases mentioned above, or affecting or
questioning the rights of the Company or such Subsidiary to the continued
possession of the leased or subleased premises under any such lease or
sublease.
(y) No
labor disturbance by the employees of the Company or any of its Subsidiaries
exists or, to the best of the Company’s knowledge, is imminent, and the Company
is not aware of any existing or imminent labor disturbance by the employees of
any of its or its Subsidiaries’ principal suppliers, manufacturers, customers or
contractors, that could reasonably be expected, singularly or in the aggregate,
to have a Material Adverse Effect. The Company is not aware that any
key employee or significant group of employees of the Company or any Subsidiary
plans to terminate employment with the Company or any such
Subsidiary. No executive officer, to the knowledge of the Company,
is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing
matters. The Company and its Subsidiaries are in compliance with all
U.S. federal, state, local and foreign laws and regulations relating to
employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance has not had and
could not, individually or in the aggregate, have or reasonably be expected to
have a Material Adverse Effect.
13
(z) No
“prohibited transaction” (as defined in Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published
interpretations thereunder (“ERISA”), or Section 4975 of
the Internal Revenue Code of 1986, as amended from time to time (the “Code”)) or “accumulated
funding deficiency” (as defined in Section 302 of ERISA) or any of the events
set forth in Section 4043(b) of ERISA (other than events with respect to which
the thirty (30)-day notice requirement under Section 4043 of ERISA has been
waived) has occurred or could reasonably be expected to occur with respect to
any employee benefit plan of the Company or any of its Subsidiaries which could,
singularly or in the aggregate, have a Material Adverse Effect. Each
employee benefit plan of the Company or any of its Subsidiaries is in compliance
in all material respects with applicable law, including ERISA and the Code. The
Company and its Subsidiaries have not incurred and could not reasonably be
expected to incur liability under Title IV of ERISA with respect to the
termination of, or withdrawal from, any pension plan (as defined in
ERISA). Each pension plan for which the Company or any of its
Subsidiaries would have any liability that is intended to be qualified under
Section 401(a) of the Code is so qualified, and nothing has occurred, whether by
action or by failure to act, which could, singularly or in the aggregate, cause
the loss of such qualification.
(aa) The
Company and its Subsidiaries are in compliance with all foreign, federal, state
and local rules, laws and regulations relating to the use, treatment, storage
and disposal of hazardous or toxic substances or waste and protection of health
and safety or the environment which are applicable to their businesses (“Environmental Laws”), except
where the failure to comply would not, singularly or in the aggregate, have a
Material Adverse Effect. There has been no storage, generation,
transportation, handling, treatment, disposal, discharge, emission, or other
release of any kind of toxic or other wastes or other hazardous substances by,
due to, or caused by the Company or any of its Subsidiaries (or, to the
Company’s knowledge, any other entity for whose acts or omissions the Company or
any of its Subsidiaries is or may otherwise be liable) upon any of the property
now or previously owned or leased by the Company or any of its Subsidiaries, or
upon any other property, in violation of any law, statute, ordinance, rule,
regulation, order, judgment, decree or permit or which would, under any law,
statute, ordinance, rule (including rule of common law), regulation, order,
judgment, decree or permit, give rise to any liability, except for any violation
or liability which would not have, singularly or in the aggregate with all such
violations and liabilities, a Material Adverse Effect; and there has been no
disposal, discharge, emission or other release of any kind onto such property or
into the environment surrounding such property of any toxic or other wastes or
other hazardous substances with respect to which the Company has knowledge,
except for any such disposal, discharge, emission, or other release of any kind
which would not have, singularly or in the aggregate with all such discharges
and other releases, a Material Adverse Effect. In the ordinary course
of business, the Company and its Subsidiaries conduct periodic reviews of the
effect of Environmental Laws on their business and assets, in the course of
which they identify and evaluate associated costs and liabilities (including,
without limitation, any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws or Governmental
Permits issued thereunder, any related constraints on operating activities and
any potential liabilities to third parties). On the basis of such
reviews, the Company and its Subsidiaries have reasonably concluded that such
associated costs and liabilities would not have, singularly or in the aggregate,
a Material Adverse Effect.
14
(bb) The
Company and its Subsidiaries, each (i) has timely filed all necessary federal,
state, local and foreign tax returns, and all such returns were true, complete
and correct, (ii) has paid all federal, state, local and foreign taxes,
assessments, governmental or other charges due and payable for which it is
liable, including, without limitation, all sales and use taxes and all taxes
which the Company or any of its Subsidiaries is obligated to withhold from
amounts owing to employees, creditors and third parties, and (iii) does not have
any tax deficiency or claims outstanding or assessed or, to the best of its
knowledge, proposed against any of them, except those, in each of the cases
described in clauses (i), (ii) and (iii) of this paragraph (bb), that
would not, singularly or in the aggregate, have a Material Adverse Effect or are
in good faith disputed with such taxing authority and for which adequate
reserves have been established in accordance with GAAP. The Company
and its Subsidiaries each has not engaged in any transaction which is a
corporate tax shelter or which could be characterized as such by the Internal
Revenue Service or any other taxing authority. The accruals and
reserves on the books and records of the Company and its Subsidiaries in respect
of tax liabilities for any taxable period not yet finally determined are
adequate to meet any assessments and related liabilities for any such period,
and since December 31, 2008, the Company and its
Subsidiaries each has not incurred any liability for taxes other than in the
ordinary course. The term “taxes” mean all
federal, state, local, foreign, and other net income, gross income, gross
receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease,
service, service use, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, windfall profits, customs, duties or other
taxes, fees, assessments, or charges of any kind whatever, together with any
interest and any penalties, additions to tax, or additional amounts with respect
thereto. The term “returns” means all
returns, declarations, reports, statements, and other documents required to be
filed in respect to taxes.
(cc) The
Company and each of its Subsidiaries carries, or is covered by, insurance
provided by recognized, financially sound and reputable institutions with
policies in such amounts and covering such risks as is adequate for the conduct
of their respective businesses and the value of their respective properties and
as is customary for companies engaged in similar businesses in similar
industries. The Company has no reason to believe that it or any
Subsidiary will not be able (i) to renew its existing insurance coverage as and
when such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as now
conducted and at a cost that would not result in a Material Adverse
Effect. Neither the Company nor any of its Subsidiaries have been
denied any insurance coverage that they have sought or for which they have
applied.
15
(dd) The
Company and its Subsidiaries each maintains a system of internal accounting and
other controls sufficient to provide reasonable assurances that
(i) transactions are executed in accordance with management’s general or
specific authorizations; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain
accountability for assets; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the
recorded accountability for assets is compared with existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences. Except as described in the General Disclosure Package,
since the end of the Company’s most recent audited fiscal year, there has been
(A) no material weakness in the Company’s internal control over financial
reporting (whether or not remediated) and (B) no change in the Company’s
internal control over financial reporting that has materially affected, or is
reasonably likely to materially affect, the Company’s internal control over
financial reporting. The Company has established disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the Company and designed such disclosure controls and procedures to ensure that
information required to be disclosed by the Company in the reports it files or
submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission’s rules and
forms.
(ee) The
minute books of the Company and each of its Subsidiaries have been made
available to the Placement Agents and counsel for the Placement Agents, and such
books (i) contain a complete summary of all meetings and actions of the board of
directors (including each board committee) and stockholders of the Company (or
analogous governing bodies and interest holders, as applicable), and each of its
Subsidiaries since the time of its respective incorporation or organization
through the date of the latest meeting and action, and (ii) accurately in all
material respects reflect all transactions referred to in such
minutes.
(ff)
All agreements and other documents that were required to
be filed as exhibits to all reports required to be filed by the Company under
the Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, since January 1, 2006 (collectively, the “SEC Reports”) under Item 601
of Regulation S-K to which the Company or any Subsidiary is a party, have been
filed by the Company as exhibits to the SEC Reports (“Material
Agreements”). All Material Agreements are valid and
enforceable against the Company, and to the Company’s Knowledge, against the
other parties thereto, in accordance with their respective terms, except (i) as
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, or moratorium or similar laws affecting creditors’ and
contracting parties’ rights generally, and (ii) as enforceability may be subject
to general principles of equity and except as rights to indemnity and
contribution may be limited by state or federal securities laws or public policy
underlying such laws. The Company is not in breach of or default
under any of the Material Agreements, and to the Company’s knowledge, no other
party to a Material Agreement is in breach of or default under such Material
Agreement. The Company has not received a notice of termination nor
is the Company otherwise aware of any threats to terminate any of the Material
Agreements. Neither the Company, its Subsidiaries nor, to its
knowledge, any other party is in violation, breach or default of any Material
Agreement that is reasonably likely to result in a Material Adverse
Effect.
(gg) No
relationship, direct or indirect, exists between or among the Company and any of
its Subsidiaries on the one hand, and the directors, officers, stockholders (or
analogous interest holders), customers or suppliers of the Company or any of its
Subsidiaries or any of their affiliates on the other hand, which is required to
be described in the General Disclosure Package and the Prospectus or a document
incorporated by reference therein and which is not so
described.
16
(hh) Except
for any obligation described in the General Disclosure Package, no person or
entity has the right to require registration of shares of Common Stock or other
securities of the Company or any of its Subsidiaries because of the filing or
effectiveness of the Registration Statement or otherwise, except for persons and
entities who have expressly waived such right in writing or who have been given
timely and proper written notice and have failed to exercise such right within
the time or times required under the terms and conditions of such
right. Except as described in the General Disclosure Package, there
are no persons with registration rights or similar rights to have any securities
registered by the Company or any of its Subsidiaries under the Securities
Act.
(ii) Neither
the Company nor any of its Subsidiaries own any “margin securities” as that term
is defined in Regulation U of the Board of Governors of the Federal Reserve
System (the “Federal Reserve
Board”), and none of the proceeds of the sale of the Stock will be used,
directly or indirectly, for the purpose of purchasing or carrying any margin
security, for the purpose of reducing or retiring any indebtedness which was
originally incurred to purchase or carry any margin security or for any other
purpose which might cause any of the Stock to be considered a “purpose credit”
within the meanings of Regulation T, U or X of the Federal Reserve
Board.
(jj) Other
than payment to MDB Capital Group pursuant to a written agreement the terms of
which have been disclosed to the Placement Agents, neither the Company nor any
of its Subsidiaries is a party to any contract, agreement or understanding with
any person that would give rise to a valid claim against the Company or the
Placement Agents for a brokerage commission, finder’s fee or like payment in
connection with the offering and sale of the Stock or any transaction
contemplated by this Agreement, the Registration Statement, the General
Disclosure Package or the Prospectus.
(kk) No
forward-looking statement (within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act) contained in either the General
Disclosure Package or the Prospectus has been made or reaffirmed without a
reasonable basis or has been disclosed other than in good faith.
(ll) Omitted.
(mm) The
Company is subject to and in compliance in all material respects with the
reporting requirements of Section 13 or Section 15(d) of the Exchange
Act. The Common Stock is registered pursuant to Section 12(b) of the
Exchange Act and is listed on the NCM, and the Company has taken no action
designed to, or reasonably likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act or delisting the Common
Stock from the NCM, nor has the Company received any notification that the
Commission or FINRA is contemplating terminating such registration or
listing. No consent, approval, authorization or order of, or filing,
notification or registration with, the NCM is required for the listing and
trading of the Stock on the NCM.
17
(nn) The
Company is in compliance with all applicable provisions of the Xxxxxxxx-Xxxxx
Act of 2002 and all rules and regulations promulgated thereunder or implementing
the provisions thereof (the “Xxxxxxxx-Xxxxx Act”) that are
then in effect and is actively taking steps to ensure that it will be in
compliance with other applicable provisions of the Xxxxxxxx-Xxxxx Act not
currently in effect upon and at all times after the effectiveness of such
provisions.
(oo) The
Company is in compliance with all applicable corporate governance requirements
set forth in the Nasdaq Marketplace Rules that are then in effect and is
actively taking steps to ensure that it will be in compliance with other
applicable corporate governance requirements set forth in the Nasdaq Marketplace
Rules not currently in effect upon and all times after the effectiveness of such
requirements.
(pp) Neither
the Company nor any of its Subsidiaries nor, to the best of the Company’s
knowledge, any employee or agent of the Company or any Subsidiary, has made any
contribution or other payment to any official of, or candidate for, any federal,
state, local or foreign office in violation of any law (including the Foreign
Corrupt Practices Act of 1977, as amended) or of the character required to be
disclosed in the Registration Statement, the General Disclosure Package or the
Prospectus or a document incorporated by reference therein.
(qq) There
are no transactions, arrangements or other relationships between and/or among
the Company, any of its affiliates (as such term is defined in Rule 405 of the
Securities Act) and any unconsolidated entity, including, but not limited to,
any structured finance, special purpose or limited purpose entity that could
reasonably be expected to materially affect the Company’s or any of its
Subsidiaries’ liquidity or the availability of or requirements for their capital
resources required to be described in the General Disclosure Package and the
Prospectus or a document incorporated by reference therein which have not been
described as required.
(rr) There
are no outstanding loans, advances (except normal advances for business expenses
in the ordinary course of business) or guarantees or indebtedness by the Company
or any of its Subsidiaries to or for the benefit of any of the officers or
directors of the Company, any of its Subsidiaries or any of their respective
family members, except as disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus.
(ss) The
statistical and market related data included in the Registration Statement, the
General Disclosure Package and the Prospectus are based on or derived from
sources that the Company believes to be reliable and accurate, and such data
agree with the sources from which they are derived.
18
(tt) The
operations of the Company and its Subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting
requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and
regulations thereunder (collectively, the “Money Laundering Laws”), and
no Action by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any of its Subsidiaries with respect to
the Money Laundering Laws is pending, or to the best knowledge of the Company,
threatened.
(uu) Neither
the Company nor any of its Subsidiaries nor, to the knowledge of the Company,
any director, officer, agent, employee or affiliate of the Company or any of its
Subsidiaries is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will
not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any Subsidiary, joint venture
partner or other person or entity, for the purpose of financing the activities
of any person currently subject to any U.S. sanctions administered by
OFAC.
(vv) Neither
the Company nor any Subsidiary nor any of their affiliates (within the meaning
of FINRA’s NASD Conduct Rule 2720(f)(1)) directly or indirectly controls, are
controlled by, or is under common control with, or is an associated person
(within the meaning of Article I, Section 1(ee) of the By-laws of FINRA) of, any
member firm of FINRA. To the Company’s knowledge and except as
disclosed to the Representative in writing, no (i) officer or director of the
Company or its Subsidiaries, (ii) owner of 5% or more of the Company’s
unregistered securities or that of its Subsidiaries or (iii) owner of any amount
of the Company’s unregistered securities acquired within the 180-day period
prior to the filing date of the Registration Statement with the Commission, has
any direct or indirect affiliation or association with any FINRA
member. The Company will advise the Representative and its counsel if
it becomes aware that any officer, director or stockholder of the Company or its
Subsidiaries is or becomes an affiliate or associated Person of a FINRA member
participating in the Offering.
(ww) No
approval of the stockholders of the Company under the rules and regulations of
Nasdaq (including Rule 5635 of the Nasdaq Marketplace Rules) is required for the
Company to issue and deliver to the Investors the Stock. Any
certificate signed by or on behalf of the Company and delivered to the Placement
Agents or to counsel for the Placement Agent shall be deemed to be a
representation and warranty by the Company to the Placement Agents and the
Investors as to the matters covered thereby.
(xx) The
Company and its Board of Directors have taken all necessary action, if any, to
render inapplicable any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company’s certificate of incorporation or the
laws of the State of Delaware that is or could become applicable to any of the
Investors as of result of the Investors and the Company fulfilling their
obligations or exercising their rights under this Agreement, including without
limitation, as a result of the Company’s issuance of the Stock and the
Investors’ ownership of the Stock.
19
(yy) Based
on the financial condition of the Company as of the Closing Date (and assuming
the Closing shall have occurred), (i) the Company’s fair saleable value of its
assets exceeds the amount that will be required to be paid or in respect of the
Company’s existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company’s assets do not constitute
unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business
conducted by the Company, and projected capital requirements and capital
availability thereof; and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive at the Closing, were it to liquidate
all of its assets, after taking into account all anticipated uses of the cash,
would be sufficient to pay all amounts on or in respect of its debt when such
amounts are required to be paid. The Company does not intend to incur
debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its
debt).
3A.
Representations and Warranties of the Selling
Shareholders. Each
Selling Shareholder, severally and not jointly, represents and warrants to, and
agrees with, the Placement Agents and the Investors that:
(a) Such
Selling Shareholder has, and immediately prior to the Closing Date the Selling
Shareholder will have, good and valid title to, or a valid “security
entitlement” within the meaning of Section 8-501 of the New York Uniform
Commercial Code (the “UCC”) in respect of, the
shares of Stock to be sold by the Selling Shareholders hereunder on such date,
free and clear of all Liens delivery of the Shares to be sold by such Selling
Shareholder and payment therefor pursuant to the Subscription Agreements will
pass valid title to such shares of Stock, free and clear of any adverse claim
within the meaning of Section 8-102 of the New York Uniform Commercial Code, to
each Purchaser who has purchased such Stock without notice of an adverse
claim
(b) This
Agreement has been duly authorized, executed and delivered by or on behalf of
such Selling Shareholder.
(c) Such
Selling Shareholder has full right, power and authority to enter into this
Agreement and the Subscription Agreements and the Escrow Agreement; the
execution, delivery and performance of this Agreement and the Subscription
Agreements and the Escrow Agreement by such Selling Shareholder, the
consummation by such Selling Shareholder of the transactions contemplated hereby
and thereby and the compliance by such Selling Shareholder with its obligations
hereunder and thereunder have been duly authorized and do not and will not (with
or without notice or lapse of time or both) conflict with or result in a breach
or violation of any of the terms or provisions of, constitute a default under,
or give rise to the creation or imposition of any Lien upon the Stock to be sold
by such Selling Shareholder hereunder or any other property or assets of such
Selling Shareholder pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which such Selling Shareholder is
a party or by which the Selling Shareholder is bound or to which any of the
property or assets of the Selling Shareholder is subject, nor will such actions
result in any violation of the provisions of any charter or by-laws (or
analogous governing instruments, as applicable) or the articles of partnership
or the deed of trust, as applicable, of the Selling Shareholder or any law,
statute, rule, regulation, judgment, order or decree of any court or
governmental agency or body, domestic or foreign, having jurisdiction over the
Selling Shareholder or any property or assets of the Selling Shareholder; and,
except for the registration of the Stock under the Securities Act and such
consents, approvals, authorizations, registrations or qualifications as may be
required under applicable state securities laws in connection with the purchase
of the Stock by the Purchasers, no consent, approval, authorization or order of,
or filing or registration with, any such court or governmental or
non-governmental agency or body is required for the execution, delivery and
performance of this Agreement or the Subscription Agreements or the Escrow
Agreement, and the consummation by such Selling Shareholder of the transactions
contemplated hereby and thereby.
20
(d) Such
Selling Shareholder has duly and irrevocably authorized, executed and delivered
the Escrow Agreement, pursuant to which such Selling Shareholder has placed in
escrow with the escrow agent named therein for delivery under the Subscription
Agreements certificates for all of the shares of Stock to be sold by such
Selling Shareholder hereunder, in negotiable and suitable form for transfer or
delivery or accompanied by duly executed instruments of transfer or assignment
in blank; and the Escrow Agreement is a valid and binding agreement of such
Selling Shareholder, enforceable against such Selling Shareholder in accordance
with its terms. The escrow agent named in the escrow agreement is
authorized to deliver the Stock to be sold by such Selling Shareholder hereunder
and to accept payment therefor.
(e) The
shares of Stock represented by the certificates held in escrow under the Escrow
Agreement for such Selling Shareholder are subject to the interests of the
Investors; the arrangements made by such Selling Shareholder for such escrow and
the escrow agent are irrevocable; the obligations of such Selling Shareholder
hereunder shall not be terminated by operation of law (whether by death or
incapacity of any individual Selling Shareholder or, in the case of an estate or
trust Selling Shareholder, by the death or incapacity of any executor or trustee
thereof or the termination of such trust or estate, or in the case of a
partnership or corporation Selling Shareholder, by the dissolution or
liquidation of such partnership or corporation, or by the occurrence of any
other event); and if any individual Selling Shareholder or trustee or executor
of any estate or trust Selling Shareholder should die or become incapacitated,
if any estate or trust Selling Shareholder should be terminated, if any
partnership or corporation Selling Shareholder should be dissolved or liquidated
or if any other event should occur before the delivery of the Stock to the
Investors, certificates for the Stock to be sold by such Selling Shareholder
shall be delivered on behalf of such Selling Shareholder in accordance with the
terms and conditions of this Agreement and the Subscription Agreement and all
action taken by the Selling Shareholder or by the escrow agent under the Escrow
Agreement shall be as valid, in each such case as if such death, incapacity,
termination, dissolution, liquidation or other event had not occurred, whether
or not the escrow agent under the Escrow Agreement shall have notice of such
death, incapacity, termination, dissolution, liquidation or other
event.
21
(f) At
the respective times the Registration Statement became or become effective, at
the date of this Agreement and at the Closing Date, the Registration Statement
did not and will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the
statements therein not misleading; and the General Disclosure Package, the
Prospectus and any amendments or supplements thereto, at the time the Prospectus
or any amendment or supplement thereto was issued and at the Applicable Time and
at the Closing Date, did not and will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; provided, however, that the
foregoing representations and warranties in this paragraph (d) apply only to the
extent that any information contained in or omitted from the Registration
Statement or Prospectus was made in reliance upon and in conformity with
information furnished to the Company in writing by such Selling
Shareholder.
(g) Such
Selling Shareholder has not taken, directly or indirectly, any action designed
or intended to stabilize or manipulate the price of any security of the Company,
or which caused or resulted in, or which might reasonably be expected to cause
or result in, the stabilization or manipulation of the price of any security of
the Company.
(h) Neither
the Selling Shareholder nor any of its affiliates (within the meaning of FINRA
Conduct Rule 2720(b)(1)(a)) directly or indirectly controls, is controlled by,
or is under common control with, or is an associated person (within the meaning
of Article I, Section 1(ee) of the By-laws of the FINRA) of, any member firm of
the FINRA, other than as described on the FINRA Questionnaire previously
completed and executed by such Selling Shareholder, a copy of which has been
provided to the Placement Agents.
(i)
Any certificate signed by or on behalf of a
Selling Shareholder and delivered to the Placement Agents or to counsel for the
Placement Agents shall be deemed to be a representation and warranty by such
Selling Shareholder to the Placement Agents and the Purchasers from such Selling
Shareholders, individually, severally and not jointly, as to the matters covered
thereby, including this Agreement.
4.
The Closing. The
time and date of closing and delivery of the documents required to be delivered
to the Placement Agents pursuant to Sections 5 and 7 hereof shall be at
10:00 A.M., New York time, on December 21, 2009 (the “Closing Date”) at the office
of DLA Piper LLP (US), 0000 Xxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxxx
00000.
5.
Further Agreements of the
Company. The
Company agrees with the Placement Agent and the Investors:
22
(a) To
prepare the Rule 462(b) Registration Statement, if necessary, in a form approved
by the Placement Agent and file such Rule 462(b) Registration Statement with the
Commission on the date hereof; to prepare the Prospectus in a form approved by
the Placement Agent containing information previously omitted at the time of
effectiveness of the Registration Statement in reliance on rules 430A, 430B and
430C and to file such Prospectus pursuant to Rule 424(b) of the Rules and
Regulations not later than the second (2nd)
business day following the execution and delivery of this Agreement or, if
applicable, such earlier time as may be required by Rule 430A of the Rules and
Regulations; to notify the Representative immediately of the Company’s intention
to file or prepare any supplement or amendment to any Registration Statement or
to the Prospectus and to make no amendment or supplement to the Registration
Statement, the General Disclosure Package or to the Prospectus to which the
Representative shall reasonably object by notice to the Company after a
reasonable period to review; to advise the Representative, promptly after it
receives notice thereof, of the time when any amendment to any Registration
Statement has been filed or becomes effective or any supplement to the General
Disclosure Package or the Prospectus or any amended Prospectus has been filed
and to furnish the Placement Agents copies thereof; to file promptly all
material required to be filed by the Company with the Commission pursuant to
Rule 433(d) or 163(b)(2), as the case may be; to file promptly all reports and
any definitive proxy or information statements required to be filed by the
Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of the Prospectus and for so long as the
delivery of a prospectus (or in lieu thereof, the notice referred to in Rule
173(a) of the Rules and Regulations) is required in connection with the offering
or sale of the Stock; to advise the Representative, promptly after it receives
notice thereof, of the issuance by the Commission of any stop order or of any
order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus, of the suspension of the
qualification of the Stock for offering or sale in any jurisdiction, of the
initiation or threatening of any proceeding for any such purpose, or of any
request by the Commission for the amending or supplementing of the Registration
Statement, the General Disclosure Package or the Prospectus or for additional
information; and, in the event of the issuance of any stop order or of any order
preventing or suspending the use of any Preliminary Prospectus, any Issuer Free
Writing Prospectus or the Prospectus or suspending any such qualification, and
promptly to use its best efforts to obtain the withdrawal of such
order.
(b) The
Company represents and agrees that, unless it obtains the prior consent of the
Representative, and each Placement Agent represents and agrees that, unless it
obtains the prior consent of the Representative and the Company, it has not made
and will not, make any offer relating to the Stock that would constitute a “free
writing prospectus” as defined in Rule 405 of the Rules and Regulations unless
the prior written consent of the Representative has been received (each, a
“Permitted Free Writing
Prospectus”); provided that the prior
written consent of the Representative hereto shall be deemed to have been given
in respect of the Issuer Free Writing Prospectuses included in Schedule A
hereto. The Company represents that it has treated and agrees that it
will treat each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus, comply with the requirements of Rules 164 and 433 of the Rules and
Regulations applicable to any Issuer Free Writing Prospectus, including the
requirements relating to timely filing with the Commission, legending and record
keeping and will not take any action that would result in the Placement Agents
or the Company being required to file with the Commission pursuant to Rule
433(d) of the Rules and Regulations a free writing prospectus prepared by or on
behalf of such Placement Agents that such Placement Agents otherwise would not
have been required to file thereunder.
23
(c) If
at any time when a Prospectus relating to the Stock is required to be delivered
under the Securities Act, any event occurs or condition exists as a result of
which the Prospectus, as then amended or supplemented, would include any untrue
statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in light of the circumstances under which they
were made, not misleading, or the Registration Statement, as then amended or
supplemented, would include any untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein not misleading,
or if for any other reason it is necessary at any time to amend or supplement
any Registration Statement or the Prospectus to comply with the Securities Act
or the Exchange Act, the Company will promptly notify the Representative, and
upon the Representative’s request, the Company will promptly prepare and file
with the Commission, at the Company’s expense, an amendment to the Registration
Statement or an amendment or supplement to the Prospectus that corrects such
statement or omission or effects such compliance and will deliver to the
Placement Agents, without charge, such number of copies thereof as the Placement
Agents may reasonably request. The Company consents to the use of the
Prospectus or any amendment or supplement thereto by the Placement
Agents.
(d) If
the General Disclosure Package is being used to solicit offers to buy the Stock
at a time when the Prospectus is not yet available to prospective Investors and
any event shall occur as a result of which, in the judgment of the Company or in
the reasonable opinion of the Representative, it becomes necessary to amend or
supplement the General Disclosure Package in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, or to make the statements therein not conflict with the information
contained or incorporated by reference in the Registration Statement then on
file and not superseded or modified, or if it is necessary at any time to amend
or supplement the General Disclosure Package to comply with any law, the Company
promptly will either (i) prepare, file with the Commission (if required) and
furnish to the Placement Agents and any dealers an appropriate amendment or
supplement to the General Disclosure Package or (ii) prepare and file with the
Commission an appropriate filing under the Exchange Act which shall be
incorporated by reference in the General Disclosure Package so that the General
Disclosure Package as so amended or supplemented will not, in the light of the
circumstances under which they were made, be misleading or conflict with the
Registration Statement then on file, or so that the General Disclosure Package
will comply with law.
(e) If
at any time following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or will conflict with the information contained in
the Registration Statement, Pricing Prospectus, if any, or Prospectus, including
any document incorporated by reference therein and any prospectus supplement
deemed to be a part thereof and not superseded or modified or included or would
include an untrue statement of a material fact or omitted or would omit to state
a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading, the Company has promptly notified or will promptly notify
the Representative so that any use of the Issuer Free Writing Prospectus may
cease until it is amended or supplemented and has promptly amended or will
promptly amend or supplement, at its own expense, such Issuer Free Writing
Prospectus to eliminate or correct such conflict, untrue statement or
omission. The foregoing sentence does not apply to statements in or
omissions from any Issuer Free Writing Prospectus in reliance upon, and in
conformity with, written information furnished to the Company by the Placement
Agents specifically for inclusion therein, which information the parties hereto
agree is limited to the Placement Agents’ Information.
24
(f)
To furnish promptly to the Placement
Agents and to counsel for the Placement Agents a signed copy of the Registration
Statement as originally filed with the Commission, and of each amendment thereto
filed with the Commission, including all consents and exhibits filed
therewith.
(g) To
deliver promptly to the Placement Agents in New York City such number of the
following documents as the Placement Agents shall reasonably
request: (i) conformed copies of the Registration Statement as
originally filed with the Commission (in each case excluding exhibits), (ii)
each Preliminary Prospectus, if any, (iii) any Issuer Free Writing Prospectus,
(iv) the Prospectus (the delivery of the documents referred to in clauses (i),
(ii), (iii) and (iv) of this paragraph (g) to be
made not later than 10:00 A.M., New York time, on the business day following the
execution and delivery of this Agreement), (v) conformed copies of any amendment
to the Registration Statement (excluding exhibits), (vi) any amendment or
supplement to the General Disclosure Package or the Prospectus (the delivery of
the documents referred to in clauses (v) and (vi) of this paragraph (g) to be
made not later than 10:00 A.M., New York City time, on the business day
following the date of such amendment or supplement) and (vii) any document
incorporated by reference in the General Disclosure Package or the Prospectus
(excluding exhibits thereto) (the delivery of the documents referred to in
clause (vii) of this paragraph (g) to be
made not later than 10:00 A.M., New York City time, on the business day
following the date of such document).
(h) To
make generally available to its stockholders as soon as practicable, but in any
event not later than eighteen (18) months after the effective date of each
Registration Statement (as defined in Rule 158(c) of the Rules and Regulations),
an earnings statement of the Company and its Subsidiaries (which need not be
audited) complying with Section 11(a) of the Securities Act and the Rules and
Regulations (including, at the option of the Company, Rule 158); and to furnish
to its stockholders as soon as practicable after the end of each fiscal year an
annual report (including a balance sheet and statements of income, stockholders’
equity and cash flows of the Company and its consolidated subsidiaries certified
by independent public accountants) and as soon as possible after each of the
first three fiscal quarters of each fiscal year (beginning with the first fiscal
quarter after the effective date of such Registration Statement), consolidated
summary financial information of the Company and its Subsidiaries for such
quarter in reasonable detail.
25
(i)
To take promptly from time to time such actions as the
Representative may reasonably request to qualify the Stock for offering and sale
under the securities or Blue Sky laws of such jurisdictions (domestic or
foreign) as the Representative may designate and to continue such qualifications
in effect, and to comply with such laws, for so long as required to permit the
offer and sale of Stock in such jurisdictions; provided that the Company and
its Subsidiaries shall not be obligated to qualify as foreign corporations in
any jurisdiction in which they are not so qualified or to file a general consent
to service of process in any jurisdiction.
(j)
Upon request, during the period of one (1) year from the date
hereof, to the extent not available on the Commission’s XXXXX system, to deliver
to the Placement Agents, (i) as soon as they are available, copies of all
reports or other communications furnished to stockholders, and (ii) as soon as
they are available, copies of any reports and financial statements furnished or
filed with the Commission or any national securities exchange or automatic
quotation system on which the Stock is listed or quoted.
(k) That
the Company will not, for a period of ninety (90) days from the date of the
Prospectus, (the “Lock-Up
Period”) without the prior written consent of the Representative,
directly or indirectly offer, sell, assign, transfer, pledge, contract to sell,
or otherwise dispose of, any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock, other than the
Company’s sale of the Stock hereunder and the issuance of restricted Common
Stock or options to acquire Common Stock pursuant to the Company’s employee
benefit plans, qualified stock option plans or other employee compensation plans
as such plans are in existence on the date hereof and described in the
Prospectus and the issuance of Common Stock pursuant to the valid exercises of
options, warrants or rights outstanding on the date hereof. The
Company will cause each executive officer, director, stockholder, optionholder
and warrantholder listed in Schedule B to furnish to the
Representative, prior to the Closing Date, a letter, substantially in the form
of Exhibit
B
hereto, pursuant to which each such person shall agree, among other things, not
to directly or indirectly offer, sell, assign, transfer, pledge, contract to
sell, or otherwise dispose of, any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock, not to engage
in any swap or other agreement or arrangement that transfers, in whole or in
part, directly or indirectly, the economic risk of ownership of Common Stock or
any such securities and not to engage in any short selling of any Common Stock
or any such securities, during the Lock-Up Period, without the prior written
consent of the Representative. The Company also agrees that during
such period, the Company will not file any registration statement, preliminary
prospectus or prospectus, or any amendment or supplement thereto, under the
Securities Act for any such transaction or which registers, or offers for sale,
Common Stock or any securities convertible into or exercisable or exchangeable
for Common Stock, except for a registration statement on Form S-8 relating to
employee benefit plans. The Company hereby agrees that (i) if it
issues an earnings release or material news, or if a material event relating to
the Company occurs, during the last seventeen (17) days of the Lock-Up Period,
or (ii) if prior to the expiration of the Lock-Up Period, the Company announces
that it will release earnings results during the sixteen (16)-day period
beginning on the last day of the Lock-Up Period, the restrictions imposed by
this paragraph
(k) or the letter shall continue to apply until the expiration of the
eighteen (18)-day period beginning on the issuance of the earnings release or
the occurrence of the material news or material event.
26
(l)
To supply the Representative with copies of all correspondence
to and from, and all documents issued to and by, the Commission in connection
with the registration of the Stock under the Securities Act or the Registration
Statement, any Preliminary Prospectus or the Prospectus, or any amendment or
supplement thereto or document incorporated by reference therein.
(m) Prior
to the Closing Date, to furnish to the Placement Agents, as soon as they have
been prepared, copies of any unaudited interim consolidated financial statements
of the Company for any periods subsequent to the periods covered by the
financial statements appearing in the Registration Statement and the
Prospectus.
(n) Prior
to the Closing Date, not to issue any press release or other communication
directly or indirectly or hold any press conference with respect to the Company,
its condition, financial or otherwise, or earnings, business affairs or business
prospects (except for routine oral marketing communications in the ordinary
course of business and consistent with the past practices of the Company and of
which the Representative is notified), without the prior written consent of the
Representative, unless in the judgment of the Company and its counsel, and after
notification to the Representative, such press release or communication is
required by law.
(o) Until
the Representative shall have notified the Company of the completion of the
offering of the Stock, that the Company will not, and will cause its affiliated
Investors (as defined in Regulation M under the Exchange Act) not to, either
alone or with one or more other persons, bid for or purchase, for any account in
which it or any of its affiliated Investors has a beneficial interest, any
Stock, or attempt to induce any person to purchase any Stock; and not to, and to
cause its affiliated Investors not to, make bids or purchase for the purpose of
creating actual, or apparent, active trading in or of raising the price of the
Stock.
(p) Not
to take any action prior to the Closing Date which would require the Prospectus
to be amended or supplemented pursuant to Section
5.
(q) To
at all times comply with all applicable provisions of the Xxxxxxxx-Xxxxx Act in
effect from time to time.
(r) To
apply the net proceeds from the sale of the Stock as set forth in the
Registration Statement, the General Disclosure Package and the Prospectus under
the heading “Use of Proceeds.”
(s)
To use its best efforts to list, subject to notice of
issuance, the Stock on the effect and maintain the quotation of the Stock on the
NCM.
(t) To
use its best efforts to assist the Representative with any filings with FINRA
and obtaining clearance from FINRA as to the amount of compensation allowable or
payable to the Placement Agent.
27
(u) To
use its best efforts to do and perform all things required to be done or
performed under this Agreement by the Company prior to the Closing Date and to
satisfy all conditions precedent to the delivery of the Stock.
5A.
Further Agreements of the Selling
Shareholders. Each
Selling Shareholder, severally and not jointly, agrees with the Placement Agent
and the Investors:
(a) Such
Selling Shareholder will not, during the Lock-Up Period without the prior
written consent of the Representative, directly or indirectly offer, sell,
assign, transfer, pledge, contract to sell, or otherwise dispose of, any shares
of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock, other than the Company’s sale of the Stock
hereunder and the issuance of restricted Common Stock or options to acquire
Common Stock pursuant to the Company’s employee benefit plans, qualified stock
option plans or other employee compensation plans as such plans are in existence
on the date hereof and described in the Prospectus and the issuance of Common
Stock pursuant to the valid exercises of options, warrants or rights outstanding
on the date hereof. Each Selling Stockholder shall furnish to the
Representative, prior to the Closing Date, a letter, substantially in the form
of Exhibit
B
hereto, pursuant to which each such person shall agree, among other things, not
to directly or indirectly offer, sell, assign, transfer, pledge, contract to
sell, or otherwise dispose of, any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock, not to engage
in any swap or other agreement or arrangement that transfers, in whole or in
part, directly or indirectly, the economic risk of ownership of Common Stock or
any such securities and not to engage in any short selling of any Common Stock
or any such securities, during the Lock-Up Period, without the prior written
consent of the Representative. Each Selling Stockholder hereby agrees
that (i) if the Company issues an earnings release or material news, or if a
material event relating to the Company occurs, during the last seventeen (17)
days of the Lock-Up Period, or (ii) if prior to the expiration of the Lock-Up
Period, the Company announces that it will release earnings results during the
sixteen (16)-day period beginning on the last day of the Lock-Up Period, the
restrictions imposed by this paragraph (k) or the
letter shall continue to apply until the expiration of the eighteen (18)-day
period beginning on the issuance of the earnings release or the occurrence of
the material news or material event.
(b) Such
Selling Shareholder will not take, directly or indirectly, any action designed
or intended to stabilize or manipulate the price of any security of the Company,
or that might reasonably be expected to cause or result in the stabilization or
manipulation of the price of any security of the Company.
(c) Such
Selling Shareholder will deliver to the Representative on or prior to the
Closing Date a properly completed and executed United States Treasury Department
Form W-8 (if the Selling Shareholder is a non-United States person) or Form W-9
(if the Selling Shareholder is a United States person) or such other applicable
form or statement specified by Treasury Department regulations in lieu
thereof.
28
(d) Such
Selling Shareholder agrees that it will not prepare or have prepared on its
behalf or use or refer to any free writing prospectus and agrees that it will
not distribute any written materials in connection with the offer or sale of the
Stock.
(e) During
the period when delivery of a prospectus (or, in lieu thereof, the notice
referred to under Rule 173(a) of the Rules and Regulations) is required under
the Securities Act, such Selling Shareholder will advise the Representative
promptly, and will confirm such advice in writing to the Representative, of any
change in the information relating to such Selling Shareholder in the
Registration Statement, the Prospectus or any document comprising the General
Disclosure Package.
(f) Such
Selling Shareholder will use his, her or its best efforts to do and perform all
things required to be done or performed under this Agreement by such Selling
Shareholder prior to the Closing Date and to satisfy all conditions precedent to
the delivery of the Stock.
6. Payment of
Expenses. The
Company agrees to pay, or reimburse if paid by the Placement Agents, whether or
not the transactions contemplated hereby are consummated or this Agreement is
terminated: (a) the costs incident to the authorization, issuance,
sale, preparation and delivery of the Stock to the Investors and any taxes
payable in that connection; (b) the costs incident to the registration of the
Stock under the Securities Act; (c) the costs incident to the preparation,
printing and distribution of the Registration Statement, the Base Prospectus,
any Preliminary Prospectus, any Issuer Free Writing Prospectus, the General
Disclosure Package, the Prospectus, any amendments, supplements and exhibits
thereto or any document incorporated by reference therein and the costs of
printing, reproducing and distributing any transaction document by mail, telex
or other means of communications; (d) the fees and expenses (including
reasonable fees and expenses of counsel for the Placement Agents) incurred in
connection with securing any required review by FINRA of the terms of the sale
of the Stock and any filings made with FINRA; (e) any applicable listing,
quotation or other fees; (f) the fees and expenses (including reasonable fees
and expenses of counsel to the Placement Agents) of qualifying the Stock under
the securities laws of the several jurisdictions as provided in Section 5(i) and of
preparing, printing and distributing wrappers, Blue Sky Memoranda and Legal
Investment Surveys; (g) the cost of preparing and printing stock certificates;
(h) all fees and expenses of the registrar and transfer agent of the Stock; (i)
the reasonable fees, disbursements and expenses of counsel to the Placement
Agents and (j) all other costs and expenses incident to the offering of the
Stock or the performance of the obligations of the Company and the Selling
Shareholders under this Agreement, the Subscription Agreements and the Escrow
Agreement (including, without limitation, the fees and expenses of the Company’s
and the Selling Shareholders’ counsel and the Company’s independent accountants
and the travel and other expenses incurred by Company personnel in connection
with any “road show” including, without limitation, any expenses advanced by the
Placement Agent on the Company’s behalf (which will be promptly
reimbursed)).
Each
Selling Shareholder will pay all fees and expenses incident to the performance
of such Selling Shareholder’s obligations under this Agreement and the
Subscription Agreements which are not otherwise specifically provided for
herein, including but not limited to any fees and expenses of counsel for such
Selling Shareholder and all expenses and taxes incident to the sale and delivery
of the Stock to be sold by such Selling Shareholder to the
Investors.
29
7.
Conditions to the Obligations of the
Placement Agents and the Investors, and the Sale of the Stock. The
respective obligations of the Placement Agents hereunder and the Investors under
the Subscription Agreements, and the Closing of the sale of the Stock, are
subject to the accuracy, when made and as of the Applicable Time and on the
Closing Date, of the representations and warranties of the Company and the
Selling Shareholders contained herein, to the accuracy of the statements of the
Company and the Selling Shareholders made in any certificates pursuant to the
provisions hereof, to the performance by the Company and the Selling
Shareholders of its obligations hereunder, and to each of the following
additional terms and conditions:
(a) No
stop order suspending the effectiveness of the Registration Statement or any
part thereof, preventing or suspending the use of any Base Prospectus, any
Preliminary Prospectus, the Prospectus or any Permitted Free Writing Prospectus
or any part thereof shall have been issued and no proceedings for that purpose
or pursuant to Section 8A under the Securities Act shall have been initiated or
threatened by the Commission, and all requests for additional information on the
part of the Commission (to be included or incorporated by reference in the
Registration Statement or the Prospectus or otherwise) shall have been complied
with to the reasonable satisfaction of the Placement Agent; the Rule 462(b)
Registration Statement, if any, each Issuer Free Writing Prospectus, if any, and
the Prospectus shall have been filed with the Commission within the applicable
time period prescribed for such filing by, and in compliance with, the Rules and
Regulations and in accordance with 5(a), and the Rule
462(b) Registration Statement, if any, shall have become effective immediately
upon its filing with the Commission; and FINRA shall have raised no objection to
the fairness and reasonableness of the terms of this Agreement or the
transactions contemplated hereby.
(b) The
Placement Agents shall not have discovered and disclosed to the Company on or
prior to the Closing Date that the Registration Statement or any amendment or
supplement thereto contains an untrue statement of a fact which, in the opinion
of counsel for the Placement Agents, is material or omits to state any fact
which, in the opinion of such counsel, is material and is required to be stated
therein or is necessary to make the statements therein not misleading, or that
the General Disclosure Package, any Issuer Free Writing Prospectus or the
Prospectus or any amendment or supplement thereto contains an untrue statement
of fact which, in the opinion of such counsel, is material or omits to state any
fact which, in the opinion of such counsel, is material and is necessary in
order to make the statements, in the light of the circumstances in which they
were made, not misleading.
(c) All
corporate proceedings and other legal matters incident to the authorization,
form and validity of each of this Agreement, the Subscription Agreements, the
Escrow Agreement, the Stock, the Registration Statement, the General Disclosure
Package, each Issuer Free Writing Prospectus, if any, and the Prospectus and all
other legal matters relating to this Agreement and the transactions contemplated
hereby shall be reasonably satisfactory in all material respects to counsel for
the Placement Agents, and the Company and the Selling Shareholders shall have
furnished to such counsel all documents and information that they may reasonably
request to enable them to pass upon such matters.
30
(d) Xxxxxx
Xxxxxx LLP shall
have furnished to the Placement Agents such counsel’s written opinion, as
counsel to the Company, addressed to the Placement Agents and the Investors and
dated the Closing Date, in form of Exhibit C attached
hereto.
Such
counsel shall also have furnished to the Placement Agents a written statement,
addressed to the Placement Agents and dated the Closing Date, in form and
substance satisfactory to the Placement Agents, to the effect that (x) such
counsel has acted as counsel to the Company in connection with the preparation
of the Registration Statement, the General Disclosure Package and the
Prospectus, and each amendment or supplement thereto made by the Company prior
to the Closing Date, (y) based on such counsel’s examination of the Registration
Statement, the General Disclosure Package and the Prospectus, and each amendment
or supplement thereto made by the Company prior to the Closing Date and the
documents incorporated by reference in the General Disclosure Package or the
Prospectus and any further amendment or supplement to any such incorporated
document made by the Company prior to the Closing Date, and such counsel’s
investigations made in connection with the preparation of the Registration
Statement, the General Disclosure Package and the Prospectus, and each amendment
or supplement thereto made by the Company prior to the Closing Date, and
“conferences with certain officers and employees of and with auditors for and
counsel to the Company,” such counsel has no reason to believe that (I) the
Registration Statement or any amendment thereto, at the Applicable Time as of
the date of this Agreement, contained any untrue statement of a material fact or
omitted to state any material fact required to be stated therein or necessary in
order to make the statements therein not misleading, or that the Prospectus or
any amendment or supplement thereto, at the respective date thereof or at the
Closing Date, contained or contains any untrue statement of a material fact or
omits to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, the documents included in the General Disclosure Package, all
considered together, as of the Applicable Time, contained or contains any untrue
statement of a material fact or omits to state any material fact necessary in
order to make the statements therein, in the light of the circumstances under
which they were made, not misleading, or (II) any document incorporated by
reference in the Prospectus or any further amendment or supplement to any such
incorporated document made by the Company prior to the Closing Date, when they
became effective or were filed with the Commission, as the case may be,
contained, in the case of a registration statement which became effective under
the Securities Act, any untrue statement of a material fact or omitted to state
any material fact required to be stated therein or necessary in order to make
the statements therein not misleading, or, in the case of other documents which
were filed under the Exchange Act with the Commission, any untrue statement of a
material fact or omitted to state any material fact necessary in order to make
the statements therein, in light of the circumstances under which they were
made, not misleading; it being understood that such counsel need express no
opinion as to the financial statements or other financial data contained in the
Registration Statement, the General Disclosure Package, or the Prospectus, or an
incorporated document. The foregoing statement may be qualified by a
statement to the effect that such counsel has not independently verified the
accuracy, completeness or fairness of the statements contained in the
Registration Statement, the General Disclosure Package or the Prospectus and
takes no responsibility therefor except to the extent set forth in the opinion
described above.
31
(e) The
Placement Agents shall have received from DLA Piper LLP (US), counsel for the
Placement Agents, such opinion or opinions, dated the Closing Date, with respect
to such matters as the Placement Agents may reasonably require, and the Company
and the Selling Shareholders shall have furnished to such counsel such documents
as they request for enabling them to pass upon such matters.
(f) At
the time of the execution of this Agreement, the Placement Agents shall have
received from each of Xxxxxxx & Company, P.A. and X.X. Xxxx LLP a letter, addressed to
the Placement Agents and the Board of Directors of the Company, executed and
dated such date, in form and substance satisfactory to the Representative (i)
confirming that they are an independent registered accounting firm with respect
to the Company and its Subsidiaries within the meaning of the Securities Act and
the Rules and Regulations and PCAOB and (ii) stating the conclusions and
findings of such firm, of the type ordinarily included in accountants’ “comfort
letters” to underwriters, with respect to the consolidated financial statements
and certain financial information contained or incorporated by reference in the
Registration Statement, the General Disclosure Package and the
Prospectus.
(g) On
the effective date of any post-effective amendment to any Registration Statement
and on the Closing Date, the Placement Agents shall have received a letter (the
“Bring-Down Letter”)
from each of Xxxxxxx & Company, P.A. and X.X. Xxxx LLP addressed to the
Placement Agents and the Board of Directors of the Company and dated the Closing
Date confirming, as of the date of the Bring-Down Letter (or, with respect to
matters involving changes or developments since the respective dates as of which
specified financial information is given in the General Disclosure Package and
the Prospectus, as the case may be, as of a date not more than three (3)
business days prior to the date of the Bring-Down Letter), the conclusions and
findings of such firm, of the type ordinarily included in accountants’ “comfort
letters” to underwriters, with respect to the financial information and other
matters covered by its letter delivered to the Placement Agents and the Board of
Directors of the Company concurrently with the execution of this Agreement
pursuant to paragraph (f) of this Section 7.
32
(h) The
Company shall have furnished to the Placement Agents and the Investors a
certificate, dated the Closing Date, of its President stating that (i) such
officers have carefully examined the Registration Statement, the General
Disclosure Package, any Permitted Free Writing Prospectus and the Prospectus
and, in their opinion, the Registration Statement and each amendment thereto, at
the Applicable Time and as of the date of this Agreement and as of the Closing
Date did not include any untrue statement of a material fact and did not omit to
state a material fact required to be stated therein or necessary to make the
statements therein not misleading, and the General Disclosure Package, as of the
Applicable Time and as of the Closing Date, any Permitted Free Writing
Prospectus as of its date and as of the Closing Date, the Prospectus and each
amendment or supplement thereto, as of the respective date thereof and as of the
Closing Date, did not include any untrue statement of a material fact and did
not omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances in which they were made, not
misleading, (ii) since the effective date of the Initial Registration
Statement, no event has occurred which should have been set forth in a
supplement or amendment to the Registration Statement, the General Disclosure
Package or the Prospectus and (iii) to the best of their knowledge after
reasonable investigation, as of the Closing Date, the representations and
warranties of the Company in this Agreement are true and correct and the Company
has complied with all agreements and satisfied all conditions on its part to be
performed or satisfied hereunder at or prior to the Closing Date.
(i) Each
Selling Shareholder shall have furnished to the Placement Agents on the Closing
Date a certificate, dated the such date, signed by, or on behalf of, such
Selling Shareholder stating that the representations, warranties and agreements
of such Selling Shareholder contained herein are true and correct as of the
Closing Date and that such Selling Shareholder has complied with all agreements
contained herein to be performed by such Selling Shareholder at or prior to the
Closing Date.
(j) There
has been no event or occurrence which, in the Representative’s determination,
has had, or could reasonably be expected to have, Material Adverse Effect during
the period from and after the date of this Agreement and prior to the applicable
Closing Date.
(k) Since
the date of the latest audited financial statements included in the General
Disclosure Package or incorporated by reference in the General Disclosure
Package as of the date hereof, (i) neither the Company nor any of its
Subsidiaries shall have sustained any loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor dispute or court or governmental action, order or
decree, otherwise than as set forth in the General Disclosure Package, and (ii)
there shall not have been any change in the capital stock or long-term debt of
the Company nor any of its Subsidiaries, or any change, or any development
involving a prospective change, in or affecting the business, general affairs,
management, financial position, stockholders’ equity or results of operations of
the Company and its Subsidiaries, otherwise than as set forth in the General
Disclosure Package, the effect of which, in any such case described in clause
(i) or (ii) of this paragraph (i), is, in the
judgment of the Representative, so material and adverse as to make it
impracticable or inadvisable to proceed with the sale or delivery of the Stock
on the terms and in the manner contemplated in the General Disclosure
Package.
(l) No
action shall have been taken and no law, statute, rule, regulation or order
shall have been enacted, adopted or issued by any governmental agency or body
which would prevent the issuance or sale of the Stock or materially and
adversely affect or potentially materially and adversely affect the business or
operations of the Company or its Subsidiaries; and no injunction, restraining
order or order of any other nature by any federal or state court of competent
jurisdiction shall have been issued which would prevent the issuance or sale of
the Stock or materially and adversely affect or potentially materially and
adversely affect the business or operations of the Company or its
Subsidiaries.
33
(m) Subsequent
to the execution and delivery of this Agreement there shall not have occurred
any of the following: (i) trading in securities generally on the New
York Stock Exchange, Nasdaq Global Market, Nasdaq Capital Market or the American
Stock Exchange or in the over-the-counter market, or trading in any securities
of the Company on any exchange or in the over-the-counter market, shall have
been suspended or materially limited, or minimum or maximum prices or maximum
range for prices shall have been established on any such exchange or such market
by the Commission, by such exchange or market or by any other regulatory body or
governmental authority having jurisdiction, (ii) a banking moratorium shall have
been declared by Federal or state authorities or a material disruption has
occurred in commercial banking or securities settlement or clearance services in
the United States, (iii) the United States shall have become engaged in
hostilities, or the subject of an act of terrorism, or there shall have been an
outbreak of or escalation in hostilities involving the United States, or there
shall have been a declaration of a national emergency or war by the United
States or (iv) there shall have occurred such a material adverse change in
general economic, political or financial conditions (or the effect of
international conditions on the financial markets in the United States shall be
such) as to make it, in the judgment of the Placement Agent, impracticable or
inadvisable to proceed with the sale or delivery of the Stock on the terms and
in the manner contemplated in the General Disclosure Package and the
Prospectus.
(n) The
NCM shall have approved the Stock for listing thereon, subject only to official
notice of issuance.
(o) The
Representative shall have received the written agreements, substantially in the
form of Exhibit
B
hereto, of the executive officers, directors, stockholders, optionholders and
warrantholders of the Company listed in Schedule B to this
Agreement.
(p) The
Company and the Selling Shareholders shall have entered into Subscription
Agreements with each of the Investors and such agreements shall be in full force
and effect.
(q) The
Shareholders shall have entered into the Escrow Agreement and such agreement
shall be in full force and effect.
(r) Omitted.
(s) The
Placement Agents shall have received clearance from FINRA as to the amount of
compensation allowable or payable to the Placement Agents as described in the
Prospectus or such pre-clearance shall not be required in the judgment of the
Placement Agents.
34
(t) Prior
to the Closing Date, the Company and the Selling Shareholders shall have
furnished to the Representative such further information, opinions,
certificates, letters or documents as the Placement Agent shall have reasonably
requested.
All
opinions, letters, evidence and certificates mentioned above or elsewhere in
this Agreement shall be deemed to be in compliance with the provisions hereof
only if they are in form and substance reasonably satisfactory to counsel for
the Placement Agent.
8. Indemnification and
Contribution.
(a) The Company and the Selling
Shareholders.
(i) The
Company shall indemnify and hold harmless the Placement Agents, its affiliates
and each of its and their respective directors, officers, members, employees,
representatives and agents of the Placement Agents and their respective
affiliates, and each of their respective directors, officers, members,
employees, representatives and agents and each person, if any, who controls the
Placement Agents within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act) and each person, if any, who controls the
Placement Agent within the meaning of Section 15 of the Securities Act of or
Section 20 of the Exchange Act (collectively, the “Placement Agent Indemnified
Parties,” and each a “Placement Agent Indemnified
Party”) against any Loss, joint or several, to which such Placement Agent
Indemnified Party may become subject, under the Securities Act or otherwise,
insofar as such Loss arises out of or is based upon (A) any untrue statement or
alleged untrue statement of a material fact contained in any Preliminary
Prospectus, any Issuer Free Writing Prospectus, any “issuer information” filed
or required to be filed pursuant to Rule 433(d) of the Rules and Regulations,
any Registration Statement or the Prospectus, or in any amendment or supplement
thereto or document incorporated by reference therein, or (B) the
omission or alleged omission to state in any Preliminary Prospectus, any Issuer
Free Writing Prospectus, any “issuer information” filed or required to be filed
pursuant to Rule 433(d) of the Rules and Regulations, any Registration Statement
or the Prospectus, or in any amendment or supplement thereto or document
incorporated by reference therein, a material fact required to be stated therein
or necessary to make the statements therein not misleading (C) any breach of the
representations and warranties of the Company contained herein, failure of the
Company to perform its obligations hereunder or pursuant to any law, any act or
failure to act, or any alleged act or failure to act, by the Placement Agent in
connection with, or relating in any manner to, the Stock, or the Offering, and
which is included as part of or referred to in any Loss arising out of or based
upon matters covered by subclause (A), (B) or (C) above of this Section 8(a) (provided that the Company
shall not be liable in the case of any matter covered by this subclause (C) to
the extent that it is determined in a final judgment by a court of competent
jurisdiction that such Loss resulted directly from any such act or failure to
act undertaken or omitted to be taken by such Placement Agent through its gross
negligence or willful misconduct), and shall reimburse the Placement Agent
Indemnified Party promptly upon demand for any legal fees or other expenses
reasonably incurred by that Placement Agent Indemnified Party in connection with
investigating, or preparing to defend, or defending against, or appearing as a
third party witness in respect of, or otherwise incurred in connection with, any
such Loss, as such Loss is incurred; provided, however, that the
Company shall not be liable in any such case to the extent that any such Loss
arises out of or is based upon an untrue statement or alleged untrue statement
in, or omission or alleged omission from any Preliminary Prospectus, any
Registration Statement or the Prospectus, or any such amendment or supplement
thereto, or any Issuer Free Writing Prospectus made in reliance upon and in
conformity with written information furnished to the Company by the Placement
Agents specifically for use therein, which information the parties hereto agree
is limited to the Placement Agents’ Information. This indemnity
agreement is not exclusive and will be in addition to any liability, which the
Company might otherwise have and shall not limit any rights or remedies which
may otherwise be available at law or in equity to each Placement Agent
Indemnified Party.
35
(ii) The
Selling Shareholders, severally and not jointly, shall indemnify and hold
harmless each Placement Agent Indemnified Party, against any Loss (or any
action, investigation or proceeding in respect thereof), joint or several, to
which that Placement Agent Indemnified Party may become subject, under the
Securities Act or otherwise, insofar as such Loss arises out of or is based upon
(i) any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any
“issuer information” filed or required to be filed pursuant to Rule 433(d) of
the Rules and Regulations, any Registration Statement or the Prospectus, or in
any amendment or supplement thereto or document incorporated by reference
therein, or (ii) the omission or alleged omission to state in any Preliminary
Prospectus, any Issuer Free Writing Prospectus, any “issuer information” filed
or required to be filed pursuant to Rule 433(d) of the Rules and Regulations,
any Registration Statement or the Prospectus, or in any amendment or supplement
thereto or document incorporated by reference therein, a material fact required
to be stated therein or necessary to make the statements therein not misleading
but in each case only to the extent that the untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in
conformity with written information provided to the Company by or on behalf of a
Selling Shareholders, and shall reimburse each Placement Agent Indemnified Party
promptly upon demand for any legal or other expenses reasonably incurred by that
Placement Agent Indemnified Party in connection with investigating or preparing
to defend or defending against or appearing as a third party witness in
connection with any such Loss, as such Loss is incurred; provided, however, that the Selling
Shareholders shall not be liable in any such case to the extent that any such
Loss arises out of or is based upon an untrue statement or alleged untrue
statement in or omission or alleged omission from any Preliminary Prospectus,
any Registration Statement or the Prospectus, or any such amendment or
supplement thereto, made in reliance upon and in conformity with written
information furnished to the Company by the Placement Agents specifically for
use therein or the Company specifically for use therein, which information the
parties hereto agree is limited to the Placement Agents’
Information. This indemnity agreement is not exclusive and will be in
addition to any liability which the Selling Shareholders might have under this
Agreement or otherwise, and shall not limit any rights or remedies which may
otherwise be available under this Agreement, at law or in equity to each
Placement Agent Indemnified Party.
36
(b) The
Placement Agents shall indemnify and hold harmless the Company and its
directors, its officers who signed the Registration Statement and each person,
if any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act, and the Selling Shareholders
(collectively, the “Company
Indemnified Parties,” and each a “Company Indemnified Party”)
against any Loss whatsoever (or any action, investigation or proceeding in
respect thereof), joint or several, to which such Company Indemnified Party may
become subject, under the Securities Act or otherwise, insofar as such Loss
arises out of or is based upon (i) any untrue statement or alleged untrue
statement of a material fact contained in any Preliminary Prospectus, any Issuer
Free Writing Prospectus, any “issuer information” filed or required to be filed
pursuant to Rule 433(d) of the Rules and Regulations, any Registration Statement
or the Prospectus, or in any amendment or supplement thereto, or (ii) the
omission or alleged omission to state in any Preliminary Prospectus, any Issuer
Free Writing Prospectus, any “issuer information” filed or required to be filed
pursuant to Rule 433(d) of the Rules and Regulations, any Registration Statement
or the Prospectus, or in any amendment or supplement thereto, a material fact
required to be stated therein or necessary to make the statements therein not
misleading, but in each case only to the extent that the untrue statement or
alleged untrue statement or omission or alleged omission was made in reliance
upon and in conformity with written information furnished to the Company by the
Placement Agent specifically for use therein, which information the parties
hereto agree is limited to the Placement Agents’ Information, and shall
reimburse the Company for any legal or other expenses reasonably incurred by
such party in connection with investigating or preparing to defend or defending
against or appearing as third party witness in connection with any such Loss, as
such Loss is incurred. Notwithstanding the provisions of this Section 8(b), in no
event shall any indemnity by the Placement Agents under this Section 8(b) exceed
the total compensation received by such Placement Agents in accordance with
Section
2.5.
37
(c) Promptly
after receipt by an indemnified party under this Section 8 of notice
of the commencement of any action, the indemnified party shall, if a claim in
respect thereof is to be made against an indemnifying party under this Section 8, notify
such indemnifying party in writing of the commencement of that action; provided, however, that the
failure to notify the indemnifying party shall not relieve it from any liability
which it may have under this Section 8 except to
the extent it has been materially prejudiced by such failure; and, provided, further, that the
failure to notify an indemnifying party shall not relieve it from any liability
which it may have to an indemnified party otherwise than under this Section
8. If any such action shall be brought against an indemnified
party, and it shall notify the indemnifying party thereof, the indemnifying
party shall be entitled to participate therein and, to the extent that it
wishes, jointly with any other similarly notified indemnifying party, to assume
the defense of such action with counsel reasonably satisfactory to the
indemnified party (which counsel shall not, except with the written consent of
the indemnified party, be counsel to the indemnifying party). After
notice from the indemnifying party to the indemnified party of its election to
assume the defense of such action, except as provided herein, the indemnifying
party shall not be liable to the indemnified party under Section 8 for any
legal or other expenses subsequently incurred by the indemnified party in
connection with the defense of such action other than reasonable costs of
investigation; provided,
however, that any indemnified party shall have the right to employ
separate counsel in any such action and to participate in the defense of such
action but the fees and expenses of such counsel (other than reasonable costs of
investigation) shall be at the expense of such indemnified party unless (i) the
employment thereof has been specifically authorized in writing by the Company in
the case of a claim for indemnification under Section 8(a)(i), the
Selling Shareholders in the case of a claim for indemnification under Section 8(a)(ii) or
Section 2.6 or
the Placement Agents in the case of a claim for indemnification under Section 8(b), (ii)
such indemnified party shall have been advised by its counsel that there may be
one or more legal defenses available to it which are different from or
additional to those available to the indemnifying party, or (iii) the
indemnifying party has failed to assume the defense of such action and employ
counsel reasonably satisfactory to the indemnified party within a reasonable
period of time after notice of the commencement of the action or the
indemnifying party does not diligently defend the action after assumption of the
defense, in which case, if such indemnified party notifies the indemnifying
party in writing that it elects to employ separate counsel at the expense of the
indemnifying party, the indemnifying party shall not have the right to assume
the defense of (or, in the case of a failure to diligently defend the action
after assumption of the defense, to continue to defend) such action on behalf of
such indemnified party and the indemnifying party shall be responsible for legal
or other expenses subsequently incurred by such indemnified party in connection
with the defense of such action; provided, however, that the
indemnifying party shall not, in connection with any one such action or separate
but substantially similar or related actions in the same jurisdiction arising
out of the same general allegations or circumstances, be liable for the
reasonable fees and expenses of more than one separate firm of attorneys at any
time for all such indemnified parties (in addition to any local counsel), which
firm shall be designated in writing by the Representative if the indemnified
parties under this Section 8 consist of
any Placement Agent Indemnified Party or by the Company if the indemnified
parties under this Section 8 consist of
any Company Indemnified Parties. Subject to this Section 8(c),
the amount payable by an indemnifying party under Section 8 shall
include, but not be limited to, (x) reasonable legal fees and expenses of
counsel to the indemnified party and any other expenses in investigating, or
preparing to defend or defending against, or appearing as a third party witness
in respect of, or otherwise incurred in connection with, any action,
investigation, proceeding or claim, and (y) all amounts paid in settlement of
any of the foregoing. No indemnifying party shall, without the prior
written consent of the indemnified parties, settle or compromise or consent to
the entry of judgment with respect to any pending or threatened action or any
claim whatsoever, in respect of which indemnification or contribution could be
sought under this Section 8
(whether or not the indemnified parties are actual or potential parties
thereto), unless such settlement, compromise or consent (i) includes an
unconditional release of each indemnified party in form and substance reasonably
satisfactory to such indemnified party from all liability arising out of such
action or claim and (ii) does not include a statement as to or an admission of
fault, culpability or a failure to act by or on behalf of any indemnified
party. Subject to the provisions of the following sentence, no
indemnifying party shall be liable for settlement of any pending or threatened
action or any claim whatsoever that is effected without its written consent
(which consent shall not be unreasonably withheld or delayed), but if settled
with its written consent, if its consent has been unreasonably withheld or
delayed or if there be a judgment for the plaintiff in any such matter, the
indemnifying party agrees to indemnify and hold harmless any indemnified party
from and against any Loss by reason of such settlement or
judgment. In addition, if at any time an indemnified party shall have
requested that an indemnifying party reimburse the indemnified party for fees
and expenses of counsel, such indemnifying party agrees that it shall be liable
for any settlement of the nature contemplated herein effected without its
written consent if (i) such settlement is entered into more than forty-five (45)
days after receipt by such indemnifying party of the request for reimbursement,
(ii) such indemnifying party shall have received notice of the terms of such
settlement at least thirty (30) days prior to such settlement being entered into
and (iii) such indemnifying party shall not have reimbursed such indemnified
party in accordance with such request prior to the date of such
settlement.
38
(d) If the
indemnification provided for in this Section
8 is unavailable or insufficient to hold harmless an indemnified party
under Section
8(a) or Section 8(b),
then each indemnifying party shall, in lieu of indemnifying such indemnified
party, contribute to the amount paid, payable or otherwise incurred by such
indemnified party as a result of such Loss, as incurred, (i) in such proportion
as shall be appropriate to reflect the relative benefits received by the Company
and the Selling Shareholders on the one hand and the Placement Agents on the
other hand from the offering of the Stock, or (ii) if the allocation provided by
clause (i) of this Section
8(d) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
of this Section
8(d) but also the relative fault of the Company on the one hand and the
Placement Agent on the other with respect to the statements, omissions, acts or
failures to act which resulted in such Loss as well as any other relevant
equitable considerations. The relative benefits received by the Company
and the Selling Shareholders on the one hand and the Placement Agents on the
other with respect to such offering shall be deemed to be in the same proportion
as the total net proceeds from the offering of the Stock purchased under this
Agreement (before deducting expenses) received by the Company and the Selling
Shareholders bear to the total Placement Fee received by the Placement Agents in
connection with the Offering, in each case as set forth in the table on the
cover page of the Prospectus. The relative fault of the Company and the
Selling Shareholders on the one hand and the Placement Agents on the other shall
be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company and the Selling
Shareholders on the one hand or the Placement Agents on the other, the intent of
the parties and their relative knowledge, access to information and opportunity
to correct or prevent such untrue statement, omission, act or failure to act;
provided
that the parties hereto agree that the written information furnished to the
Company by the Placement Agents for use in the Preliminary Prospectus, any
Registration Statement or the Prospectus, or in any amendment or supplement
thereto, consists solely of the Placement Agents’ Information. The Company
and the Selling Shareholders and the Placement Agents agree that it would not be
just and equitable if contributions pursuant to this Section
8(d) were to be determined by pro rata allocation or by any other method
of allocation that does not take into account the equitable considerations
referred to herein. The amount paid or payable by an indemnified party as
a result of the Loss referred to above in this Section
8(d) shall be deemed to include, for purposes of this Section
8(d), any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating, preparing to defend or defending against
or appearing as a third party witness in respect of, or otherwise incurred in
connection with, any such Loss. Notwithstanding the provisions of this
Section
8(d), the Placement Agents shall not be required to contribute any amount
in excess of the total compensation received by the Placement Agents in
accordance with Section
2.5 less the amount of any damages which the Placement Agents have
otherwise paid or become liable to pay by reason of any untrue or alleged untrue
statement, omission or alleged omission, act or alleged act or failure to act or
alleged failure to act. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. The Placement Agents’ obligations to contribute as
provided in this Section
8(d) are several in proportion to the amount of the Placement Fee
received by each of them and not
joint.
39
9. Termination. The
obligations of the Placement Agents and the Investors hereunder and under the
Subscription Agreements may be terminated by the Representative, in its absolute
discretion by notice given to the Company prior to delivery of and payment for
the Stock if, prior to that time, any of the events described in Sections 7(k) or
7(m) have
occurred or if the Investors shall decline to purchase the Stock for any reason
permitted under this Agreement or the Subscription Agreements.
10. Reimbursement of Placement Agents’
Expenses. Notwithstanding
anything to the contrary in this Agreement, if (a) this Agreement shall have
been terminated pursuant to Section 9, (b) the Company
and the Selling Shareholders shall fail to tender the Stock for delivery to the
Investors for any reason not permitted under this Agreement (provided a
reasonable cure period of no more than two Business Days is permitted during
which transfer agent or transmittal delays with respect to the Selling
Shareholder Stock shall be permitted if outside the reasonable control of the
Company or the Selling Shareholders), (c) the Investors shall decline to
purchase the Stock for any reason permitted under this Agreement or (d) the sale
of the Stock is not consummated because any condition to the obligations of the
Investors or the Placement Agents set forth herein is not satisfied or because
of the refusal, inability or failure on the part of the Company or any Selling
Shareholder to perform any agreement herein or to satisfy any condition or to
comply with the provisions hereof, then, in addition to the payment of any
amounts in accordance with Section 6, the
Company and each Selling Shareholder shall reimburse the Placement Agents for
the reasonable fees and expenses of the Placement Agents’ counsel and for such
other out-of-pocket expenses as shall have been reasonably incurred by them in
connection with this Agreement and the proposed purchase of the Stock, and upon
demand the Company and the Selling Shareholders shall pay the full amount
thereof to the Placement Agents.
11. Authority of the
Representative. MCF
consents and agrees that RBCCM will act as Representative of the Placement
Agents under this Agreement and with respect to the sale of the
Stock. Accordingly, MCF authorizes RBCCM to manage the Offering and
the sale of the Stock and to take such action in connection therewith as RBCCM
in its sole discretion deems appropriate or desirable, consistent with the
provisions of each Agreement Among Underwriters previously entered into between
RBCCM and MCF, taking into account that the Offering of the Stock will be in the
form of a best efforts placement and not a firm commitment
underwriting. MCF agrees to comply with such Agreement Among
Underwriters and that any action taken under this Agreement by the
Representative shall be binding upon all of the Placement Agents.
40
12. Absence of Fiduciary
Relationship. The
Company and the Selling Shareholders acknowledge and agree
that:
(a) the
Placement Agents’ responsibility to the Company and the Selling Shareholders is
solely contractual in nature, the Placement Agents have been retained solely to
act as Placement Agents in connection with the Offering and no fiduciary,
advisory or agency relationship between the Company or the Selling Shareholders
and the Placement Agents has been created in respect of any of the transactions
contemplated by this Agreement, irrespective of whether the Placement Agents
have advised or are advising the Company or the Selling Shareholders on other
matters;
(b) the
price of the Stock set forth in this Agreement was established by the Company
and the Selling Shareholders, respectively and in the case of the Selling
Shareholders, individually, following discussions and arms-length negotiations
with the Placement Agents, and the Company and the Selling Shareholders are
capable of evaluating and understanding, and understands and accepts, the terms,
risks and conditions of the transactions contemplated by this
Agreement;
(c) they
have been advised that the Placement Agents and their respective affiliates are
engaged in a broad range of transactions which may involve interests that differ
from those of the Company and the Selling Shareholders and that the Placement
Agents have no obligation to disclose such interests and transactions to the
Company or the Selling Shareholders by virtue of any fiduciary, advisory or
agency relationship; and
(d) they
waive, to the fullest extent permitted by law, any claims it may have against
the Placement Agents for breach of fiduciary duty or alleged breach of fiduciary
duty and agrees that the Placement Agents shall have no liability (whether
direct or indirect) to the Company or the Selling Shareholders in respect of
such a fiduciary duty claim or to any person asserting a fiduciary duty claim on
behalf of or in right of the Company or the Selling Shareholders, including
stockholders, employees or creditors of the Company or the Selling
Shareholders.
13. Successors; Persons Entitled to
Benefit of Agreement. This
Agreement shall inure to the benefit of and be binding upon the Placement
Agents, the Company, the Selling Shareholders and their respective successors
and assigns. This Agreement shall also inure to the benefit of the
Representative, the Investors, and each of their respective successors and
assigns, which shall be third party beneficiaries
hereof. Notwithstanding the foregoing, as provided in the
Subscription Agreements, the determination as to whether any condition in Section 7 hereof
shall have been satisfied, and the waiver of any condition in Section 7 hereof, may
be made by the Representative in its sole discretion, and any such determination
or waiver shall be binding on each of the Investors and shall not require the
consent of any Investor. Nothing expressed or mentioned in this
Agreement is intended or shall be construed to give any person, other than the
persons mentioned in the preceding sentences, any legal or equitable right,
remedy or claim under or in respect of this Agreement, or any provisions herein
contained, this Agreement and all conditions and provisions hereof being
intended to be and being for the sole and exclusive benefit of such persons and
for the benefit of no other person; except that the representations, warranties,
covenants, agreements and indemnities of the Company and the Selling
Shareholders contained in this Agreement shall also be for the benefit of the
Placement Agent Indemnified Parties and the indemnities of the Placement Agents
shall be for the benefit of the Company Indemnified Parties. It is
understood that the Placement Agents’ responsibility to the Company and the
Selling Shareholders is solely contractual in nature and the Placement Agents do
not owe the Company or the Selling Shareholders, or any other party, any
fiduciary duty as a result of this Agreement.
41
14. Survival of Indemnities,
Representations, Warranties, etc. The respective
indemnities, covenants, agreements, representations, warranties and other
statements of the Company, the Selling Shareholders and the Placement Agents, as
set forth in this Agreement or made by them respectively, pursuant to this
Agreement, shall remain in full force and effect, regardless of any
investigation made by or on behalf of the Placement Agents, the Company, the
Selling Shareholders, the Investors or any person controlling any of them and
shall survive delivery of and payment for the Stock. Notwithstanding any
termination of this Agreement, including without limitation any termination
pursuant to Sections
9 or 10,
the indemnity and contribution agreements contained in Section
8 and the covenants, representations, warranties set forth in this
Agreement shall not terminate and shall remain in full force and effect at all
times.
15. Notices. All
statements, requests, notices and agreements hereunder shall be in writing,
and:
(a) if
to the Placement Agents, shall be delivered or sent by mail, telex, facsimile
transmission or email to the Representative, Three World Financial Center, 000
Xxxxx Xxxxxx, 0xx Xxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Xxxx X. Xxxxxx,
(000) 000-0000 (facsimile); and
(b) if
to the Company, shall be delivered or sent by mail, telex, facsimile
transmission or email to interClick, Inc., 000 Xxxx Xxxxxx Xxxxx, Xxxxx 000, Xxx
Xxxx, Xxx Xxxx 00000 Attention: Xxxxxxx Xxxxxxx, (000) 000-0000 (facsimile),
with a copy to Sichenzia Xxxx Xxxxxxxx Xxxxxxx, LLP, 00 Xxxxxxxx, XX, XX 00000,
Attention: Xxxxxx Xxxxxx, Esq. (000) 000-0000 (facsimile); and
(c) if
to any Selling Shareholders, shall be delivered or sent by mail, telex,
facsimile transmission or email to such Selling Shareholder at the address set
forth on Schedule
C hereto;
provided, however, that any
notice to the Representative pursuant to Section
8 shall be delivered or sent by mail, telex or facsimile
transmission to the Representative at its address set forth in its acceptance
telex to the Representative, which address will be supplied to any other party
hereto by the Representative upon request. Any such statements,
requests, notices or agreements shall take effect at the time of receipt
thereof, except that any such statement, request, notice or agreement delivered
or sent by email shall take effect at the time of confirmation of receipt
thereof by the recipient thereof.
16. Definition of Certain
Terms. For
purposes of this Agreement, (a) “business day” means any day on
which the NCM is open for trading and (b) “Subsidiary” has the meaning
set forth in Rule 405 of the Rules and Regulations.
42
17. Governing Law, Agent for Service and
Jurisdiction. This Agreement shall be governed by
and construed in accordance with the laws of the State of New York, including
without limitation Section 5-1401 of the New York General Obligations
Law. No legal proceeding may be commenced, prosecuted or
continued in any court other than the courts of the State of New York located in
the City and County of New York or in the United States District Court for the
Southern District of New York, which courts shall have jurisdiction over the
adjudication of such matters, and the Company, the Selling Stockholders and the
Placement Agents each hereby consent to the jurisdiction of such courts and
personal service with respect thereto. The Company, the Selling
Stockholders and the Placement Agents each hereby consent to personal
jurisdiction, service and venue in any court in which any legal proceeding
arising out of or in any way relating to this Agreement is brought by any third
party against the Company or the Placement Agents. The Company, the
Selling Stockholders and the Placement Agents each hereby waive all right to
trial by jury in any legal proceeding (whether based upon contract, tort or
otherwise) in any way arising out of or relating to this
Agreement. The Company and the Selling Stockholders agree that a
final judgment in any such legal proceeding brought in any such court shall be
conclusive and binding upon the Company, the Selling Stockholders and the
Placement Agents and may be enforced in any other courts in the jurisdiction of
which the Company and the Selling Stockholders is or may be subject, by suit
upon such judgment.
18. Placement Agents’
Information. The
parties hereto acknowledge and agree that, for all purposes of this Agreement,
the Placement Agent’s Information consists solely of the following information
in the Prospectus: (i) the first paragraph on the front cover page concerning
the terms of the offering; and (ii) the statements concerning the Placement
Agents contained in the first paragraph under the heading “Plan of
Distribution.”
19. Partial
Unenforceability. The
invalidity or unenforceability of any section, paragraph, clause or provision of
this Agreement shall not affect the validity or enforceability of any other
section, paragraph, clause or provision hereof. If any section,
paragraph, clause or provision of this Agreement is for any reason determined to
be invalid or unenforceable, there shall be deemed to be made such minor changes
(and only such minor changes) as are necessary to make it valid and
enforceable.
20. General. This
Agreement constitutes the entire agreement of the parties to this Agreement and
supersedes all prior written or oral and all contemporaneous oral agreements,
understandings and negotiations with respect to the subject matter
hereof. In this Agreement, the masculine, feminine and neuter genders
and the singular and the plural include one another. The section
headings in this Agreement are for the convenience of the parties only and will
not affect the construction or interpretation of this Agreement. This
Agreement may be amended or modified, and the observance of any term of this
Agreement may be waived, only by a writing signed by the Company, the Selling
Stockholders and the Representative.
21. Counterparts. This
Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon
the same instrument and such signatures may be delivered by
facsimile.
(Remainder
of this page intentionally left blank; signatures begin on the next
page.)
43
If the
foregoing is in accordance with your understanding of the agreement between the
Company, the Selling Shareholders and the Placement Agent, kindly indicate your
acceptance in the space provided for that purpose below.
Very
truly yours,
|
|
By:
|
/s/ Xxxxxxx Xxxxxxx |
Name:
Xxxxxxx Xxxxxxx
|
|
Title:
Chief Executive Officer
|
|
/s/ Xxxxxxx Xxxxxxx
|
|
Xxxxxxx
Xxxxxxx
|
|
/s/ Xxxxx
Xxxxx
|
|
Xxxxx
Xxxxx
|
|
BMB
HOLDINGS LLLP
|
|
By: BMB
Holdings, LLC, its General Partner
|
|
By:
|
/s/ Xxxxxxx Xxxxxxx |
Name:
Xxxxxxx Xxxxxxx
|
|
Title:
Managing Partner
|
44
Accepted
as of the date
|
|
first
above written:
|
|
RBC
CAPITAL MARKETS CORPORATION
|
|
By:
|
/s/ Xxxx X. Xxxxxx |
Name:
Xxxx X. Xxxxxx
|
|
Title:
Managing Director
|
|
XXXXXXXX
CURHAN FORD & CO.
|
|
By:
|
/s/ Xxxx Xxxx |
Name:
Xxxx Xxxx
|
|
Title:
Vice
Chairman
|
45
SCHEDULE A
General
Use Free Writing Prospectuses
None.
SCHEDULE B
List
of officers, directors, stockholders, optionholders and
warrantholders
subject to Section 5
Xxxxxxx
Xxxxxxx
BMB
Holdings LLLP
Xxxxx
Xxxxx
Xxxxxxx
Xxxxxxx
Xxxxx
Xxxxx
Xxxxxxx
Xxxx
Xxxxxx
Xxxx
Xxxxx
Xxxxxxx
Xxxxx
Xxxx
SCHEDULE
C
SELLING SHAREHOLDERS
|
NUMBER OF SHARES OF
STOCK OF STOCK TO BE
SOLD
|
PURCHASE PRICE
|
||||||
BMB
HOLDINGS LLLP
000
X. Xxxxxxx Xxxxxxx
Xxxxx
000
Xxxx
Xxxxx, XX 00000
Facsimile: ___________
|
517,500 | $ | ||||||
Xxxxxxx
Xxxxxxx
c/o
interClick, Inc.
000
Xxxx Xxxxxx Xxxxx, Xxxxx 000
Xxx
Xxxx, XX 00000
Facsimile: (000)
000-0000
|
115,000 | $ | ||||||
Xxxxx
Xxxxx
000
X. Xxxxxxx Xxxxxxx
Xxxxx
000
Xxxx
Xxxxx, XX 00000
Facsimile: ___________
|
517,500 | $ | ||||||
TOTAL
|
1,150,000 |
EXHIBIT A
[Form
of Subscription Agreement]
EXHIBIT B
[Form
of Lock Up Agreement]
December
__, 2009
RBC
CAPITAL MARKETS CORPORATION
XXXXXXXX
CURHAN FORD & CO.
c/o RBC
Capital Markets Corporation
Three
World Financial Center, 000 Xxxxx Xxxxxx
Xxx Xxxx,
Xxx Xxxx 00000
Re: interCLICK,
Inc. ____ Shares of Common Stock
Ladies
and Gentlemen:
In order
to induce each of RBC Capital Markets Corporation (“RBCCM”) and Xxxxxxxx Curhan
Ford & Co. (“MCF”,
and together with RBCCM, the “Placement Agents”), to enter
in to a certain placement agent agreement with interCLICK, Inc., a Delaware
corporation (the “Company”), with respect to the
public offering of shares of the Company’s Common Stock, par value $0.001 per
share (“Common Stock”),
the undersigned hereby agrees that for a period (the “lock-up period”) of ninety
(90) days following the date of the final prospectus filed by the Company with
the Securities and Exchange Commission in connection with such public offering,
the undersigned will not, without the prior written consent of RBCCM, directly
or indirectly, (i) offer, sell, assign, transfer, pledge, contract to sell, or
otherwise dispose of, any shares of Common Stock or securities convertible into
or exercisable or exchangeable for Common Stock (including, without limitation,
shares of Common Stock or any such securities which may be deemed to be
beneficially owned by the undersigned in accordance with the rules and
regulations promulgated under the Securities Act of 1933, as the same may be
amended or supplemented from time to time (such shares or securities, the “Beneficially Owned Shares”)),
(ii) enter into any swap, hedge or other agreement or arrangement that transfers
in whole or in part, the economic risk of ownership of any Beneficially Owned
Shares, Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock, or (iii) engage in any short selling of any
Beneficially Owned Shares, Common Stock or securities convertible into or
exercisable or exchangeable for Common Stock.
If (i)
the Company issues an earnings release or material news or a material event
relating to the Company occurs during the last seventeen (17) days of the
lock-up period, or (ii) prior to the expiration of the lock-up period, the
Company announces that it will release earnings results during the sixteen
(16)-day period beginning on the last day of the lock-up period, the
restrictions imposed by this Agreement shall continue to apply until the
expiration of the eighteen (18)-day period beginning on the issuance of the
earnings release or the occurrence of the material news or material
event.
Anything
contained herein to the contrary notwithstanding, any person to whom shares of
Common Stock, securities convertible into or exercisable or exchangeable for
Common Stock or Beneficially Owned Shares are transferred from the undersigned
shall be bound by the terms of this Agreement.
In
addition, the undersigned hereby waives, from the date hereof until the
expiration of the ninety (90) day period following the date of the Company’s
final prospectus, any and all rights, if any, to request or demand registration
pursuant to the Securities Act of 1933, as amended, of any shares of Common
Stock or securities convertible into or exercisable or exchangeable for Common
Stock that are registered in the name of the undersigned or that are
Beneficially Owned Shares. In order to enable the aforesaid covenants
to be enforced, the undersigned hereby consents to the placing of legends and/or
stop transfer orders with the transfer agent of the Common Stock with respect to
any shares of Common Stock, securities convertible into or exercisable or
exchangeable for Common Stock or Beneficially Owned Shares.
[Signatory]
|
||
By:
|
||
Name:
|
||
Title:
|
EXHIBIT
C
Form
of Opinion